Chapter 1

0.   18.  Regestein QR. The big, bad obesity pandemic. Menopause. 2018;25(2):129–32.

0.   19.  Katz D. Obesity … be dammed!: what it will take to turn the tide. Harvard Health Policy Rev. 2006;7(2):135–51.

0.   20.  National Center for Health Statistics. Table 53. Selected health conditions and risk factors, by age: United States, selected years 1988–1994 through 2015–2016. 2017. Available at: https://www.cdc.gov/nchs/data/hus/2017/053.pdf. Accessed March 19, 2019.

0.   21.  Inoue Y, Qin B, Poti J, Sokol R, Gordon-Larsen P. Epidemiology of obesity in adults: latest trends. Curr Obes Rep. 2018;7(4):276–88.

0.   22.  Ludwig DS. Epidemic childhood obesity: not yet the end of the beginning. Pediatrics. 2018;141(3):1–4.

0.   23.  Skinner AC, Ravanbakht SN, Skelton JA, et al. Prevalence of obesity and severe obesity in US children, 1999–2016. Pediatrics. 2018;141(3):e20173459.

0.   24.  Helmchen LA, Henderson RM. Changes in the distribution of body mass index of white US men, 1890–2000. Ann Hum Biol. 2004;31(2):174–81.

0.   25.  Inoue Y, Qin B, Poti J, Sokol R, Gordon-Larsen P. Epidemiology of obesity in adults: latest trends. Curr Obes Rep. 2018;7(4):276–88.

0.   26.  Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804–14.

0.   27.  Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804–14.

0.   28.  Frank LD, Andresen MA, Schmid TL. Obesity relationships with community design, physical activity, and time spent in cars. Am J Prev Med. 2004;27(2):87–96.

0.   29.  Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804–14.

0.   30.  European Association for the Study of Obesity. Obesity: perception and policy—multi-country review and survey of policymakers 2014. 2014. Available at: https://web.archive.org/web/20180722003601/http://easo.org/wp-content/uploads/2014/05/C3_EASO_Survey_A4_Web-FINAL.pdf. Accessed March 19, 2019.

0.   31.  Rodgers A, Woodward A, Swinburn B, Dietz WH. Prevalence trends tell us what did not precipitate the US obesity epidemic. Lancet Public Health. 2018;3(4):e162–3.

0.   32.  Cohen DA. Neurophysiological pathways to obesity: below awareness and beyond individual control. Diabetes. 2008;57(7):1768–73.

0.   33.  Mangalindan J. PepsiCo CEO: “if all consumers exercised … obesity wouldn’t exist.” Fortune. Published April 27, 2010. Available at: http://archive.fortune.com/2010/04/27/news/companies/indra_nooyi_pepsico.fortune/index.htm. Accessed March 19, 2019.

0.   34.  Barlow P, Serôdio P, Ruskin G, McKee M, Stuckler D. Science organisations and Coca-Cola’s “war” with the public health community: insights from an internal industry document. J Epidemiol Community Health. 2018;72(9):761–3.

0.   35.  Karnani A, McFerran B, Mukhopadhyay A. Leanwashing: a hidden factor in the obesity crisis. Calif Manage Rev. 2014;56(4):5–30.

0.   36.  Scrinis G. Big Food corporations and the nutritional marketing and regulation of processed foods. Canadian Food Studies. 2015;2(2):136–45.

0.   37.  What is Nestlé doing about obesity? Nestle.com. Available at: https://www.nestle.com/ask-nestle/health-nutrition/answers/what-is-nestle-doing-about-obesity. Accessed March 19, 2019.

0.   38.  Karnani A, McFerran B, Mukhopadhyay A. Leanwashing: a hidden factor in the obesity crisis. Calif Manage Rev. 2014;56(4):5–30.

0.   39.  Flatt JP. Issues and misconceptions about obesity. Obesity (Silver Spring). 2011;19(4):676–86.

0.   40.  McFerran B, Mukhopadhyay A. Lay theories of obesity predict actual body mass. Psychol Sci. 2013;24(8):1428–36.

0.   41.  Flatt JP. Issues and misconceptions about obesity. Obesity (Silver Spring). 2011;19(4):676–86.

0.   42.  Hill JO, Wyatt HR, Peters JC. Energy balance and obesity. Circulation. 2012;126(1):126–32.

0.   43.  Swinburn B, Sacks G, Ravussin E. Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am J Clin Nutr. 2009;90(6):1453–6.

0.   44.  Vandevijvere S, Chow CC, Hall KD, Umali E, Swinburn BA. Increased food energy supply as a major driver of the obesity epidemic: a global analysis. Bull World Health Organ. 2015;93(7):446–56.

0.   45.  Westerterp KR, Speakman JR. Physical activity energy expenditure has not declined since the 1980s and matches energy expenditures of wild mammals. Int J Obes (Lond). 2008;32(8):1256–63.

0.   46.  Church T, Martin CK. The obesity epidemic: a consequence of reduced energy expenditure and the uncoupling of energy intake? Obesity (Silver Spring). 2018;26(1):14–6.

0.   47.  Bleich S, Cutler D, Murray C, Adams A. Why is the developed world obese? Annu Rev Public Health. 2008;29:273–95.

0.   48.  Tataranni PA, Harper IT, Snitker S, et al. Body weight gain in free-living Pima Indians: effect of energy intake vs expenditure. Int J Obes Relat Metab Disord. 2003;27(12):1578–83.

0.   49.  McFerran B, Mukhopadhyay A. Lay theories of obesity predict actual body mass. Psychol Sci. 2013;24(8):1428–36.

0.   50.  McFerran B, Mukhopadhyay A. Lay theories of obesity predict actual body mass. Psychol Sci. 2013;24(8):1428–36.

0.   51.  McFerran B, Mukhopadhyay A. Lay theories of obesity predict actual body mass. Psychol Sci. 2013;24(8):1428–36.

0.   52.  Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197–206.

0.   53.  Loos RJ, Yeo GS. The bigger picture of FTO: the first GWAS-identified obesity gene. Nat Rev Endocrinol. 2014;10(1):51–61.

0.   54.  Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42(11):937–48.

0.   55.  Karra E, O’Daly OG, Choudhury AI, et al. A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest. 2013;123(8):3539–51.

0.   56.  Cheung MK, Yeo GS. FTO biology and obesity: why do a billion of us weigh 3 kg more? Front Endocrinol (Lausanne). 2011;2:4.

0.   57.  Tedstone AE. Obesity treatment—are personalised approaches missing the point? BMJ. 2016;354:i4980.

0.   58.  Hall KD, Sacks G, Chandramohan D, et al. Quantification of the effect of energy imbalance on bodyweight. Lancet. 2011;378(9793):826–37.

0.   59.  Loos RJ, Yeo GS. The bigger picture of FTO: the first GWAS-identified obesity gene. Nat Rev Endocrinol. 2014;10(1):51–61.

0.   60.  Li S, Zhao JH, Luan J, et al. Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome-wide association studies. Am J Clin Nutr. 2010;91(1):184–90.

0.   61.  Kilpeläinen TO, Qi L, Brage S, et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med. 2011;8(11):e1001116.

0.   62.  Corella D, Arnett DK, Tucker KL, et al. A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and BMI. J Nutr. 2011;141(12):2219–25.

0.   63.  Livingstone KM, Celis-Morales C, Papandonatos GD, et al. FTO genotype and weight loss: systematic review and meta-analysis of 9563 individual participant data from eight randomised controlled trials. BMJ. 2016;354:i4707.

0.   64.  Celis-Morales C, Marsaux CF, Livingstone KM, et al. Can genetic-based advice help you lose weight? Findings from the Food4Me European randomized controlled trial. Am J Clin Nutr. 2017;105(5):1204–13.

0.   65.  Meisel SF, Walker C, Wardle J. Psychological responses to genetic testing for weight gain: a vignette study. Obesity (Silver Spring). 2012;20(3):540–6.

0.   66.  Centre for Economic Performance. Vertical transmission of overweight: evidence from English adoptees. Published October 2016. Available at: http://cep.lse.ac.uk/pubs/download/dp1324.pdf. Accessed March 19, 2019.

0.   67.  Knowler WC, Pettitt DJ, Saad MF, et al. Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr. 1991;53(6 Suppl):1543S–51S.

0.   68.  Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev. 1990;6(1):1–27.

0.   69.  Ravussin E. Energy metabolism in obesity. Studies in the Pima Indians. Diabetes Care. 1993;16(1):232–8.

0.   70.  Ravussin E. Energy metabolism in obesity. Studies in the Pima Indians. Diabetes Care. 1993;16(1):232–8.

0.   71.  Boyce VL, Swinburn BA. The traditional Pima Indian diet. Composition and adaptation for use in a dietary intervention study. Diabetes Care. 1993;16(1):369–71.

0.   72.  Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation. Nutr Rev. 2001;59(5):129–39.

0.   73.  Schulz LO, Bennett PH, Ravussin E, et al. Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care. 2006;29(8):1866–71.

0.   74.  Dobzhansky T. Nothing in biology makes sense except in the light of evolution. Am Biol Teach. 1973;35(3):125–9.

0.   75.  Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353–62.

0.   76.  Genné-Bacon EA. Thinking evolutionarily about obesity. Yale J Biol Med. 2014;87(2):99–112.

0.   77.  Anderson RM, Brackenridge BP. Polar bears in the jungle: reflections on obesity and overeating. Diabetes Educ. 1999;25(4):521–3.

0.   78.  Egger G, Swinburn B. An “ecological” approach to the obesity pandemic. BMJ. 1997;315(7106):477–80.

0.   79.  Pimentel GD, Ganeshan K, Carvalheira JB. Hypothalamic inflammation and the central nervous system control of energy homeostasis. Mol Cell Endocrinol. 2014;397(1–2):15–22.

0.   80.  Speakman JR. Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the “drifty gene” hypothesis. Int J Obes (Lond). 2008;32(11):1611–7.

0.   81.  Myslobodsky M, Ingraham LJ. Managing the pandemic of obesity: siding with the fox or the hedgehog? Obes Facts. 2009;2(6):384–92.

0.   82.  Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353–62.

0.   83.  Genné-Bacon EA. Thinking evolutionarily about obesity. Yale J Biol Med. 2014;87(2):99–112.

0.   84.  American Medical Association’s Council on Science and Public Health. American Medical Association’s Council on Science and Public Health report 420 (A-13). 2013. Available at: https://www.npr.org/documents/2013/jun/ama-resolution-obesity.pdf. Accessed March 19, 2019.

0.   85.  The Council on Science and Public Health. Report of the Council on Science and Public Health: CSAPH report 3-A-13. 2013. Available at: https://www.ama-assn.org/sites/ama-assn.org/files/corp/media-browser/public/about-ama/councils/Council%20Reports/council-on-science-public-health/a13csaph3.pdf. Accessed March 19, 2019.

0.   86.  Katz D. Obesity … be dammed!: what it will take to turn the tide. Harvard Health Policy Rev. 2006;7(2):135–51.

0.   87.  Rutter H. Where next for obesity? Lancet. 2011;378(9793):746–7.

0.   88.  National Center for Health Statistics. Table 53. Selected health conditions and risk factors, by age: United States, selected years 1988–1994 through 2015–2016. 2017. Available at: https://www.cdc.gov/nchs/data/hus/2017/053.pdf. Accessed March 19, 2019.

0.   89.  Newburgh LH, Johnston MW. The nature of obesity. J Clin Invest. 1930;8(2):197–213.

0.   90.  Swinburn BA. Obesity prevention: the role of policies, laws and regulations. Aust New Zealand Health Policy. 2008;5(12):1–7.

0.   91.  Brunstrom JM, Drake ACL, Forde CG, Rogers PJ. Undervalued and ignored: are humans poorly adapted to energy-dense foods? Appetite. 2018;120:589–95.

0.   92.  Gibson EL, Wardle J. Energy density predicts preferences for fruit and vegetables in 4-year-old children. Appetite. 2003;41(1):97–8.

0.   93.  Laska M, Hernandez Salazar LT, Luna ER. Food preferences and nutrient composition in captive spider monkeys, Ateles geoffroyi. Int J Primatol. 2000;21(4):671–3.

0.   94.  Brunstrom JM, Drake ACL, Forde CG, Rogers PJ. Undervalued and ignored: are humans poorly adapted to energy-dense foods? Appetite. 2018;120:589–95.

0.   95.  United States Department of Agriculture. USDA food composition databases. Available at: https://ndb.nal.usda.gov/ndb. Accessed March 19, 2019.

0.   96.  Novick J. Added oils: the elephant in the room. Dr. McDougall’s Health & Medical Center. Published February 28, 2018. Available at: https://us4.campaign-archive.com/?e=fa8b8ba4e0&u=5e58f59d97611f910916b6276&id=cc2c77335d. Accessed March 19, 2019.

0.   97.  Ifland J, Preuss HG, Marcus MT, Rourke KM, Taylor W, Theresa Wright H. Clearing the confusion around processed food addiction. J Am Coll Nutr. 2015;34(3):240–3.

0.   98.  Fortuna JL. The obesity epidemic and food addiction: clinical similarities to drug dependence. J Psychoactive Drugs. 2012;44(1):56–63.

0.   99.  Gearhardt AN, Yokum S, Orr PT, Stice E, Corbin WR, Brownell KD. Neural correlates of food addiction. Arch Gen Psychiatry. 2011;68(8):808–16.

0. 100.  Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O’Brien CP. Limbic activation during cue-induced cocaine craving. Am J Psychiatry. 1999;156(1):11–8.

0. 101.  Schneider F, Habel U, Wagner M, et al. Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry. 2001;158(7):1075–83.

0. 102.  Schulte EM, Smeal JK, Gearhardt AN. Foods are differentially associated with subjective effect report questions of abuse liability. PLoS ONE. 2017;12(8):e0184220.

0. 103.  Altmann J, Schoeller D, Altmann S, Muruthi P, Sapolsky R. Body size and fatness of free-living baboons reflect food availability and activity levels. Am J Primatol. 1993;30(2):149–61.

0. 104.  Rubio-Ruiz ME, Peredo-Escárcega AE, Cano-Martínez A, Guarner-Lans V. An evolutionary perspective of nutrition and inflammation as mechanisms of cardiovascular disease. Int J Evol Biol. 2015;2015:179791.

0. 105.  Jenkins DJ, Jenkins AL, Kendall CW, Vuksan V, Vidgen E. The garden of Eden: implications for cardiovascular disease prevention. Asia Pac J Clin Nutr. 2000;9 Suppl 1:S1–3.

0. 106.  Regestein QR. The big, bad obesity pandemic. Menopause. 2018;25(2):129–32.

0. 107.  Aronne LJ. Treatment of obesity in the primary care setting. In: Wadden TA, Stunkard AJ, eds. Handbook of Obesity Treatment. New York: The Guilford Press; 2002:383–94.

0. 108.  Battle EK, Brownell KD. Confronting a rising tide of eating disorders and obesity: treatment vs. prevention and policy. Addict Behav. 1996;21(6):755–65.

0. 109.  Maffetone PB, Laursen PB. The prevalence of overfat adults and children in the US. Front Public Health. 2017;5:290.

0. 110.  National Center for Health Statistics. Table 53. Selected health conditions and risk factors, by age: United States, selected years 1988–1994 through 2015–2016. 2017. Available at: https://www.cdc.gov/nchs/data/hus/2017/053.pdf. Accessed March 19, 2019.

0. 111.  Friedman JM. A war on obesity, not the obese. Science. 2003;299(5608):856–8.

0. 112.  Bouchard C, Tremblay A, Després JP, et al. The response to long-term overfeeding in identical twins. N Engl J Med. 1990;322(21):1477–82.

0. 113.  Bouchard C, Tremblay A, Després JP, et al. The response to exercise with constant energy intake in identical twins. Obes Res. 1994;2(5):400–10.

0. 114.  Campbell MK. Biological, environmental, and social influences on childhood obesity. Pediatr Res. 2016;79(1-2):205–11.

0. 115.  Brooks AA, Johnson MR, Steer PJ, Pawson ME, Abdalla HI. Birth weight: nature or nurture? Early Hum Dev. 1995;42(1):29–35.

0. 116.  Waterland RA. Epigenetic mechanisms affecting regulation of energy balance: many questions, few answers. Annu Rev Nutr. 2014;34:337–55.

0. 117.  Smith J, Cianflone K, Biron S, et al. Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrinol Metab. 2009;94(11):4275–83.

0. 118.  McAllister EJ, Dhurandhar NV, Keith SW, et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49(10):868–913.

0. 119.  Waterland RA. Epigenetic mechanisms affecting regulation of energy balance: many questions, few answers. Annu Rev Nutr. 2014;34:337–55.

0. 120.  McAllister EJ, Dhurandhar NV, Keith SW, et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49(10):868–913.

0. 121.  Finch CE, Loehlin JC. Environmental influences that may precede fertilization: a first examination of the prezygotic hypothesis from maternal age influences on twins. Behav Genet. 1998;28(2):101–6.

0. 122.  Keith SW, Redden DT, Katzmarzyk PT, et al. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes (Lond). 2006;30(11):1585–94.

0. 123.  Katzmarzyk PT, Barlow S, Bouchard C, et al. An evolving scientific basis for the prevention and treatment of pediatric obesity. Int J Obes (Lond). 2014;38(7):887–905.

0. 124.  Smith J, Cianflone K, Biron S, et al. Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrinol Metab. 2009;94(11):4275–83.

0. 125.  Swinburn B, Sacks G, Ravussin E. Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am J Clin Nutr. 2009;90(6):1453–6.

0. 126.  Vandevijvere S, Chow CC, Hall KD, Umali E, Swinburn BA. Increased food energy supply as a major driver of the obesity epidemic: a global analysis. Bull World Health Organ. 2015;93(7):446–56.

0. 127.  Bleich S, Cutler D, Murray C, Adams A. Why is the developed world obese? Annu Rev Public Health. 2008;29:273–95.

0. 128.  Gerrior S, Bente L, Hiza H. Nutrient content of the U.S. food supply, 1909–2000. Home Economics Research Report No. 56. United States Department of Agriculture, Center for Nutrition Policy and Promotion. Published November 2004. Available at: https://www.cnpp.usda.gov/sites/default/files/nutrient_content_of_the_us_food_supply/FoodSupply1909-2000.pdf. Accessed March 19, 2019.

0. 129.  Gerrior S, Bente L, Hiza H. Nutrient content of the U.S. food supply, 1909–2000. Home Economics Research Report No. 56. United States Department of Agriculture, Center for Nutrition Policy and Promotion. Published November 2004. Available at: https://www.cnpp.usda.gov/sites/default/files/nutrient_content_of_the_us_food_supply/FoodSupply1909-2000.pdf. Accessed March 19, 2019.

0. 130.  Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804–14.

0. 131.  Cutler D, Glaeser E, Shapiro J. Why have Americans become more obese? J Econ Perspect. 2003;17(3):93–118.

0. 132.  Cutler D, Glaeser E, Shapiro J. Why have Americans become more obese? J Econ Perspect. 2003;17(3):93–118.

0. 133.  Moodie R, Stuckler D, Monteiro C, et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet. 2013;381(9867):670–9.

0. 134.  Scrinis G. Big Food corporations and the nutritional marketing and regulation of processed foods. Canadian Food Studies. 2015;2(2):136–45.

0. 135.  Cutler D, Glaeser E, Shapiro J. Why have Americans become more obese? J Econ Perspect. 2003;17(3):93–118.

0. 136.  Cutler D, Glaeser E, Shapiro J. Why have Americans become more obese? J Econ Perspect. 2003;17(3):93–118.

0. 137.  Cutler D, Glaeser E, Shapiro J. Why have Americans become more obese? J Econ Perspect. 2003;17(3):93–118.

0. 138.  Perry CL, Creamer MR. The childhood obesity epidemic: lessons learned from tobacco. J Pediatr. 2014;164(1):178–85.

0. 139.  Centers for Disease Control and Prevention. Tobacco use—United States, 1900–1999. MMWR Morb Mortal Wkly Rep. 1999;48(43):986–93.

0. 140.  Zimmerman FJ. Using marketing muscle to sell fat: the rise of obesity in the modern economy. Annu Rev Public Health. 2011;32:285–306.

0. 141.  Siegel KR, McKeever Bullard K, Imperatore G, et al. Association of higher consumption of foods derived from subsidized commodities with adverse cardiometabolic risk among US adults. JAMA Intern Med. 2016;176(8):1124–32.

0. 142.  Franck C, Grandi SM, Eisenberg MJ. Agricultural subsidies and the American obesity epidemic. Am J Prev Med. 2013;45(3):327–33.

0. 143.  Siegel KR, McKeever Bullard K, Imperatore G, et al. Association of higher consumption of foods derived from subsidized commodities with adverse cardiometabolic risk among US adults. JAMA Intern Med. 2016;176(8):1124–32.

0. 144.  Popkin BM. Contemporary nutritional transition: determinants of diet and its impact on body composition. Proc Nutr Soc. 2011;70(1):82–91.

0. 145.  Nestle M. Utopian dream: a new farm bill. Dissent. 2012;59(2):15–9.

0. 146.  Popkin BM. Agricultural policies, food and public health. EMBO Rep. 2011;12(1):11–8.

0. 147.  Popkin BM. Contemporary nutritional transition: determinants of diet and its impact on body composition. Proc Nutr Soc. 2011;70(1):82–91.

0. 148.  Franck C, Grandi SM, Eisenberg MJ. Agricultural subsidies and the American obesity epidemic. Am J Prev Med. 2013;45(3):327–33.

0. 149.  Harvie A, Wise TA. Sweetening the pot: implicit subsidies to corn sweeteners and the US obesity epidemic. Global Development and Environment Institute. Published February 2009. Available at: http://www.ase.tufts.edu/gdae/Pubs/rp/PB09-01SweeteningPotFeb09.pdf. Accessed March 19, 2019.

0. 150.  Wise TA, Starmer E. Industrial livestock companies’ gains from low feed prices, 1997–2005. Global Development and Environment Institute. Published February 2007. Available at: http://www.ase.tufts.edu/gdae/Pubs/rp/CompanyFeedSvgsFeb07.pdf. Accessed March 19, 2019.

0. 151.  Putnam J, Allshouse J, Kantor LS. U.S. per capita food supply trends: more calories, refined carbohydrates, and fats. FoodReview. 2002;25(3):2–15.

0. 152.  King DE, Mainous AG, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults, 1988–2006. Am J Med. 2009;122(6):528–34.

0. 153.  Winson A. Bringing political economy into the debate on the obesity epidemic. Agric Human Values. 2004;21(4):299–312.

0. 154.  Winson A. Bringing political economy into the debate on the obesity epidemic. Agric Human Values. 2004;21(4):299–312.

0. 155.  Siegel KR, McKeever Bullard K, Imperatore G, et al. Association of higher consumption of foods derived from subsidized commodities with adverse cardiometabolic risk among US adults. JAMA Intern Med. 2016;176(8):1124–32.

0. 156.  Putnam J, Allshouse J, Kantor LS. U.S. per capita food supply trends: more calories, refined carbohydrates, and fats. FoodReview. 2002;25(3):2–15.

0. 157.  Putnam J, Allshouse J, Kantor LS. U.S. per capita food supply trends: more calories, refined carbohydrates, and fats. FoodReview. 2002;25(3):2–15.

0. 158.  Gerrior S, Bente L, Hiza H. Nutrient content of the U.S. food supply, 1909–2000. Home Economics Research Report No. 56. United States Department of Agriculture, Center for Nutrition Policy and Promotion. Published November 2004. Available at: https://www.cnpp.usda.gov/sites/default/files/nutrient_content_of_the_us_food_supply/FoodSupply1909-2000.pdf. Accessed March 19, 2019.

0. 159.  Rehkamp S. A look at calorie sources in the American diet. Economic Research Service, United States Department of Agriculture. Published December 5, 2016. Available at: https://www.ers.usda.gov/amber-waves/2016/december/a-look-at-calorie-sources-in-the-american-diet. Accessed March 31, 2019.

0. 160.  Nestle M. Utopian dream: a new farm bill. Dissent. 2012;59(2):15–9.

0. 161.  Morris B. Tearing up the Jack Welch playbook. Fortune. Published July 14, 2006. Available at: https://money.cnn.com/sales/executive_resource_center/articles2/rules.fortune/index.htm. Accessed March 19, 2019.

0. 162.  Nestle M. Interview with Marion Nestle. Health Promot Pract. 2008;9(1):16–8.

0. 163.  Zimmerman FJ. Using marketing muscle to sell fat: the rise of obesity in the modern economy. Annu Rev Public Health. 2011;32:285–306.

0. 164.  Consumers Union. Out of balance: marketing of soda, candy, snacks and fast foods drowns out healthful messages. California Pan-Ethnic Health Network. Published September 2005. Available at: https://cpehn.org/sites/default/files/resource_files/outofbalance.pdf. Accessed May 4, 2019.

0. 165.  Vranica S. McDonald’s to review its $2 billion global media buying account. Wall Street Journal. Published October 26, 2017. Available at: https://www.wsj.com/articles/mcdonalds-to-review-its-2-billion-global-media-buying-account-1509036600. Accessed March 19, 2019.

0. 166.  Winson A. Bringing political economy into the debate on the obesity epidemic. Agric Human Values. 2004;21(4):299–312.

0. 167.  Nestle M. Utopian dream: a new farm bill. Dissent. 2012;59(2):15–9.

0. 168.  Horgen KB, Brownell KD. Confronting the toxic environment: environmental, public health actions in a world crisis. In: Wadden TA, Stunkard AJ, eds. Handbook of Obesity Treatment. New York: The Guilford Press; 2002:95–106.

0. 169.  Lapierre MA, Fleming-Milici F, Rozendaal E, McAlister AR, Castonguay J. The effect of advertising on children and adolescents. Pediatrics. 2017;140(Suppl 2):S152–6.

0. 170.  Harris JL, Pomeranz JL, Lobstein T, Brownell KD. A crisis in the marketplace: how food marketing contributes to childhood obesity and what can be done. Annu Rev Public Health. 2009;30:211–25.

0. 171.  Harris JL, Pomeranz JL, Lobstein T, Brownell KD. A crisis in the marketplace: how food marketing contributes to childhood obesity and what can be done. Annu Rev Public Health. 2009;30:211–25.

0. 172.  James P. All-of-government approach needed to tackle obesity. Interview by Fiona Fleck. Bull World Health Organ. 2013;91(8):551–2.

0. 173.  Bond ME, Crammond BR, Loff B. It’s not about choice: the supermarket and obesity. Med J Aust. 2012;197(7):371.

0. 174.  Cohen DA. Neurophysiological pathways to obesity: below awareness and beyond individual control. Diabetes. 2008;57(7):1768–73.

0. 175.  Zimmerman FJ. Using marketing muscle to sell fat: the rise of obesity in the modern economy. Annu Rev Public Health. 2011;32:285–306.

0. 176.  Katz D. Obesity … be dammed!: what it will take to turn the tide. Harvard Health Policy Rev. 2006;7(2):135–51.

0. 177.  Institute of Medicine. Food marketing to children and youth: threat or opportunity? National Academies Press. 2006. Available at: https://www.nap.edu/catalog/11514/food-marketing-to-children-and-youth-threat-or-opportunity. Accessed on March 19, 2019.

0. 178.  Zimmerman FJ. Using marketing muscle to sell fat: the rise of obesity in the modern economy. Annu Rev Public Health. 2011;32:285–306.

0. 179.  Nestle M, Jacobson MF. Halting the obesity epidemic: a public health policy approach. Public Health Rep. 2000;115(1):12–24.

0. 180.  Fersht A. The most influential journals: Impact Factor and Eigenfactor. Proc Natl Acad Sci USA. 2009;106(17):6883–4.

0. 181.  North AC, Hargreaves DJ, McKendrick J. In-store music affects product choice. Nature. 1997;390(132):132.

0. 182.  North AC, Hargreaves DJ, McKendrick J. In-store music affects product choice. Nature. 1997;390(132):132.

0. 183.  Nestle M, Jacobson MF. Halting the obesity epidemic: a public health policy approach. Public Health Rep. 2000;115(1):12–24.

0. 184.  Stanton RA. Food retailers and obesity. Curr Obes Rep. 2015;4(1):54–9.

0. 185.  Muris TJ, Thompson MW, Swindle O, Leary TB, Jones HP. Slotting allowances in the retail grocery industry: select case studies in five product categories. Federal Trade Commission. Published November 2003. Available at: https://www.ftc.gov/sites/default/files/documents/reports/use-slotting-allowances-retail-grocery-industry/slottingallowancerpt031114.pdf. Accessed on March 21, 2019.

0. 186.  Collier R. Call to reduce junk food at checkouts. CMAJ. 2015;187(1):E14.

0. 187.  Cohen DA, Lesser LI. Obesity prevention at the point of purchase. Obes Rev. 2016;17(5):389–96.

0. 188.  Cohen DA. Neurophysiological pathways to obesity: below awareness and beyond individual control. Diabetes. 2008;57(7):1768–73.

0. 189.  Cohen DA. Neurophysiological pathways to obesity: below awareness and beyond individual control. Diabetes. 2008;57(7):1768–73.

0. 190.  Cohen DA. Neurophysiological pathways to obesity: below awareness and beyond individual control. Diabetes. 2008;57(7):1768–73.

0. 191.  Miller GA. The magical number seven plus or minus two: some limits on our capacity for processing information. Psychol Rev. 1956;63(2):81–97.

0. 192.  Shiv B, Fedorikhin A. Heart and mind in conflict: the interplay of affect and cognition in consumer decision-making. J Consum Res. 1999;26(3):278–92.

0. 193.  Zimmerman FJ, Shimoga SV. The effects of food advertising and cognitive load on food choices. BMC Public Health. 2014;14:342.

0. 194.  Zimmerman FJ, Shimoga SV. The effects of food advertising and cognitive load on food choices. BMC Public Health. 2014;14:342.

0. 195.  Cohen DA. Neurophysiological pathways to obesity: below awareness and beyond individual control. Diabetes. 2008;57(7):1768–73.

0. 196.  Nestle M. Utopian dream: a new farm bill. Dissent. 2012;59(2):15–9.

0. 197.  Cohen DA. Neurophysiological pathways to obesity: below awareness and beyond individual control. Diabetes. 2008;57(7):1768–73.

0. 198.  Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804–14.

0. 199.  Cohen DA. Neurophysiological pathways to obesity: below awareness and beyond individual control. Diabetes. 2008;57(7):1768–73.

0. 200.  Williams KJ, Wu X. Imbalanced insulin action in chronic over nutrition: clinical harm, molecular mechanisms, and a way forward. Atherosclerosis. 2016;247:225–82.

0. 201.  Poti JM, Duffey KJ, Popkin BM. The association of fast food consumption with poor dietary outcomes and obesity among children: is it the fast food or the remainder of the diet? Am J Clin Nutr. 2014;99(1):162–71.

0. 202.  Alhéritière A, Montois S, Galinski M, Tazarourte K, Lapostolle F. Worldwide relation between the number of McDonald’s restaurants and the prevalence of obesity. J Intern Med. 2013;274(6):610–1.

0. 203.  Poti JM, Duffey KJ, Popkin BM. The association of fast food consumption with poor dietary outcomes and obesity among children: is it the fast food or the remainder of the diet? Am J Clin Nutr. 2014;99(1):162–71.

0. 204.  Young LR, Nestle M. Portion sizes and obesity: responses of fast-food companies. J Public Health Policy. 2007;28(2):238–48.

0. 205.  Rolls BJ. The supersizing of America: portion size and the obesity epidemic. Nutr Today. 2003;38(2):42–53.

0. 206.  Young LR, Nestle M. Expanding portion sizes in the US marketplace: implications for nutrition counseling. J Am Diet Assoc. 2003;103(2):231–4.

0. 207.  Rolls BJ. The supersizing of America: portion size and the obesity epidemic. Nutr Today. 2003;38(2):42–53.

0. 208.  Rolls BJ. The supersizing of America: portion size and the obesity epidemic. Nutr Today. 2003;38(2):42–53.

0. 209.  Herman CP, Polivy J, Vartanian LR, Pliner P. Are large portions responsible for the obesity epidemic? Physiol Behav. 2016;156:177–81.

0. 210.  Livingstone MB, Pourshahidi LK. Portion size and obesity. Adv Nutr. 2014;5(6):829–34.

0. 211.  Almiron-Roig E, Tsiountsioura M, Lewis HB, Wu J, Solis-Trapala I, Jebb SA. Large portion sizes increase bite size and eating rate in overweight women. Physiol Behav. 2015;139:297–302.

0. 212.  Rolls BJ, Roe LS, Meengs JS. The effect of large portion sizes on energy intake is sustained for 11 days. Obesity (Silver Spring). 2007;15(6):1535–43.

0. 213.  van Kleef E, Bruggers I, de Vet E. Encouraging vegetable intake as a snack among children: the influence of portion and unit size. Public Health Nutr. 2015;18(15):2736–41.

0. 214.  Rolls BJ. What is the role of portion control in weight management? Int J Obes (Lond). 2014;38 Suppl 1:S1–8.

0. 215.  Zimmerman FJ. Using marketing muscle to sell fat: the rise of obesity in the modern economy. Annu Rev Public Health. 2011;32:285–306.

0. 216.  Cohen DA. Neurophysiological pathways to obesity: below awareness and beyond individual control. Diabetes. 2008;57(7):1768–73.

0. 217.  Taillie LS, Ng SW, Popkin BM. Global growth of “big box” stores and the potential impact on human health and nutrition. Nutr Rev. 2016;74(2):83–97.

0. 218.  Nestle M. Counting the cost of calories. Interview by Ben Jones. Bull World Health Organ. 2012;90(8):566–7.

0. 219.  Duffey KJ, Popkin BM. Energy density, portion size, and eating occasions: contributions to increased energy intake in the United States, 1977–2006. PLoS Med. 2011;8(6):e1001050.

0. 220.  Zimmerman FJ. Using marketing muscle to sell fat: the rise of obesity in the modern economy. Annu Rev Public Health. 2011;32:285–306.

0. 221.  Ludwig DS. Childhood obesity—the shape of things to come. N Engl J Med. 2007;357(23):2325–7.

0. 222.  Bonnet J, George A, Evans P, Silberberg M, Dolinsky D. Rethinking obesity counseling: having the French Fry Discussion. J Obes. 2014;2014:525021.

0. 223.  Grummer-Strawn LM, Scanlon KS, Fein SB. Infant feeding and feeding transitions during the first year of life. Pediatrics. 2008;122 Suppl 2:S36–42.

0. 224.  Katz D. Obesity … be dammed!: what it will take to turn the tide. Harvard Health Policy Rev. 2006;7(2):135–51.

0. 225.  Perry CL, Creamer MR. The childhood obesity epidemic: lessons learned from tobacco. J Pediatr. 2014;164(1):178–85.

0. 226.  McCrory MA, Suen VM, Roberts SB. Biobehavioral influences on energy intake and adult weight gain. J Nutr. 2002;132(12):3830S–4S.

0. 227.  Zimmerman FJ. Using marketing muscle to sell fat: the rise of obesity in the modern economy. Annu Rev Public Health. 2011;32:285–306.

0. 228.  McCrory MA, Suen VM, Roberts SB. Biobehavioral influences on energy intake and adult weight gain. J Nutr. 2002;132(12):3830S–4S.

0. 229.  Scrinis G. Big Food corporations and the nutritional marketing and regulation of processed foods. Canadian Food Studies. 2015;2(2):136–45.

0. 230.  Sacks G, Swinburn BA, Cameron AJ, Ruskin G. How food companies influence evidence and opinion—straight from the horse’s mouth. Crit Public Health. 2018;28(2):253–6.

0. 231.  Moodie R, Stuckler D, Monteiro C, et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet. 2013;381(9867):670–9.

0. 232.  Lobbying spending database food & beverage, 2009. Center for Responsive Politics. Available at: http://www.opensecrets.org/lobby/indusclient.php?id=n01&year=2009. Accessed March 22, 2019.

0. 233.  Citizens United v. Federal Election Commission. 130 S.Ct. 876 08–205 (Roberts Court 2010).

0. 234.  Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804–14.

0. 235.  Steier G. Dead people don’t eat: food governmentenomics and conflicts-of-interest in the USDA and FDA. J Environ Public Health. 2012;7(1):1–77.

0. 236.  Brownell KD. Thinking forward: the quicksand of appeasing the food industry. PLoS Med. 2012;9(7):e1001254.

0. 237.  Swinburn B, Vandevijvere S. WHO report on ending childhood obesity echoes earlier recommendations. Public Health Nutr. 2016;19(1):1–2.

0. 238.  Liggett & Myers Tobacco Company Campaign: Doctor ordered. Tobacco.Stanford.edu. Available at: https://stanford.io/2BfDHPx. Accessed March 21, 2019.

0. 239.  Kirk SF, Penney TL, Freedhoff Y. Running away with the facts on food and fatness. Public Health Nutr. 2010;13(1):147–8.

0. 240.  Our mission. HealthyChildren.org. Published 2009. Available at: https://web.archive.org/web/20120310054653/http://www.healthychildren.org:80/english/our-mission/sponsors/pages/default.aspx. Accessed March 21, 2019.

0. 241.  Murray JL. Coke and the AAFP—the real thing or a dangerous liaison? Fam Med. 2010;42(1):57–8.

0. 242.  Yanamadala S, Bragg MA, Roberto CA, Brownell KD. Food industry front groups and conflicts of interest: the case of Americans against food taxes. Public Health Nutr. 2012;15(8):1331–2.

0. 243.  About. Americans for Food and Beverage Choice. Available at: https://www.yourcartyourchoice.com/about-us. Accessed March 21, 2019.

0. 244.  Barnes DE, Bero LA. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law. 1996;21(3):515–42.

0. 245.  Mialon M, Mialon J. Corporate political activity of the dairy industry in France: an analysis of publicly available information. Public Health Nutr. 2017;20(13):2432–9.

0. 246.  Perry CL, Creamer MR. The childhood obesity epidemic: lessons learned from tobacco. J Pediatr. 2014;164(1):178–85.

0. 247.  Schleifer D. We spent a million bucks and then we had to do something: the unexpected implications of industry involvement in trans fat research. Bull Sci Technol Soc. 2011;31(6):460–71.

0. 248.  Perry CL, Creamer MR. The childhood obesity epidemic: lessons learned from tobacco. J Pediatr. 2014;164(1):178–85.

0. 249.  Schleifer D. We spent a million bucks and then we had to do something: the unexpected implications of industry involvement in trans fat research. Bull Sci Technol Soc. 2011;31(6):460–71.

0. 250.  Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–47.

0. 251.  Chan M. WHO Director-General addresses health promotion conference. World Health Organization. Published June 10, 2013. Available at: https://www.who.int/dg/speeches/2013/health_promotion_20130610/en. Accessed March 21, 2019.

0. 252.  Chan M. Obesity and diabetes: the slow-motion disaster. Milbank Q. 2017;95(1):11–4.

0. 253.  Chan M. Obesity and diabetes: the slow-motion disaster. Keynote address at the 47th meeting of the National Academy of Medicine. World Health Organization. Published October 17, 2016. Available at: https://www.who.int/dg/speeches/2016/obesity-diabetes-disaster/en. Accessed March 21, 2019.

0. 254.  Ortiz SE, Zimmerman FJ, Gilliam FD. Weighing in: the taste-engineering frame in obesity expert discourse. Am J Public Health. 2015;105(3):554–9.

0. 255.  Zimmerman FJ. Using marketing muscle to sell fat: the rise of obesity in the modern economy. Annu Rev Public Health. 2011;32:285–306.

0. 256.  Brownell KD, Warner KE. The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? Milbank Q. 2009;87(1):259–94.

0. 257.  Lifshitz F, Lifshitz JZ. Globesity: the root causes of the obesity epidemic in the USA and now worldwide. Pediatr Endocrinol Rev. 2014;12(1):17–34.

0. 258.  Ortiz SE, Zimmerman FJ, Gilliam FD. Weighing in: the taste-engineering frame in obesity expert discourse. Am J Public Health. 2015;105(3):554–9.

0. 259.  Hall KD, Guo J, Dore M, Chow CC. The progressive increase of food waste in America and its environmental impact. PLoS ONE. 2009;4(11):e7940.

0. 260.  Hastings G. Why corporate power is a public health priority. BMJ. 2012;345:e5124.

0. 261.  Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804–14.

0. 262.  Nestle M. The ironic politics of obesity. Science. 2003;299(5608):781.

0. 263.  Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.

0. 264.  Liu Y, Hazlewood GS, Kaplan GG, Eksteen B, Barnabe C. Impact of obesity on remission and disease activity in rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2017;69(2):157–65.

0. 265.  Aune D, Norat T, Vatten LJ. Body mass index and the risk of gout: a systematic review and dose-response meta-analysis of prospective studies. Eur J Nutr. 2014;53(8):1591–601.

0. 266.  Thijssen E, van Caam A, van der Kraan PM. Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology (Oxford). 2015;54(4):588–600.

0. 267.  Kulkarni K, Karssiens T, Kumar V, Pandit H. Obesity and osteoarthritis. Maturitas. 2016;89:22–8.

0. 268.  Kulkarni K, Karssiens T, Kumar V, Pandit H. Obesity and osteoarthritis. Maturitas. 2016;89:22–8.

0. 269.  Baudart P, Louati K, Marcelli C, Berenbaum F, Sellam J. Association between osteoarthritis and dyslipidaemia: a systematic literature review and meta-analysis. RMD Open. 2017;3(2):e000442.

0. 270.  Thijssen E, van Caam A, van der Kraan PM. Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology (Oxford). 2015;54(4):588–600.

0. 271.  Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. Framingham Study. Ann Intern Med. 1992;116(7):535–9.

0. 272.  Christensen R, Astrup A, Bliddal H. Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial. Osteoarthr Cartil. 2005;13(1):20–7.

0. 273.  Bernstein J. Not the last word: safety alert: one in 200 knee replacement patients die within 90 days of surgery. Clin Orthop Relat Res. 2017;475(2):318–23.

0. 274.  Bernstein J. Not the last word: safety alert: one in 200 knee replacement patients die within 90 days of surgery. Clin Orthop Relat Res. 2017;475(2):318–23.

0. 275.  Bernstein J. Not the last word: safety alert: one in 200 knee replacement patients die within 90 days of surgery. Clin Orthop Relat Res. 2017;475(2):318–23.

0. 276.  Bourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KD. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010;468(1):57–63.

0. 277.  Zhang TT, Liu Z, Liu YL, Zhao JJ, Liu DW, Tian QB. Obesity as a risk factor for low back pain: a meta-analysis. Clin Spine Surg. 2018;31(1):22–7.

0. 278.  Shiri R, Lallukka T, Karppinen J, Viikari-Juntura E. Obesity as a risk factor for sciatica: a meta-analysis. Am J Epidemiol. 2014;179(8):929–37.

0. 279.  Xu X, Li X, Wu W. Association between overweight or obesity and lumbar disk diseases. J Spinal Disord Tech. 2015;28(10):370–6.

0. 280.  Shiri R, Lallukka T, Karppinen J, Viikari-Juntura E. Obesity as a risk factor for sciatica: a meta-analysis. Am J Epidemiol. 2014;179(8):929–37.

0. 281.  Xu X, Li X, Wu W. Association between overweight or obesity and lumbar disk diseases. J Spinal Disord Tech. 2015;28(10):370–6.

0. 282.  Kauppila LI. Atherosclerosis and disc degeneration/low-back pain—a systematic review. Eur J Vasc Endovasc Surg. 2009;37(6):661–70.

0. 283.  Naumnik B, Myśliwiec M. Renal consequences of obesity. Med Sci Monit. 2010;16(8):RA163–70.

0. 284.  Arena R, Daugherty J, Bond S, Lavie CJ, Phillips S, Borghi-Silva A. The combination of obesity and hypertension: a highly unfavorable phenotype requiring attention. Curr Opin Cardiol. 2016;31(4):394–401.

0. 285.  Poorolajal J, Hooshmand E, Bahrami M, Ameri P. How much excess weight loss can reduce the risk of hypertension? J Public Health (Oxf). 2017;39(3):e95–102.

0. 286.  Jackson SL, King SM, Zhao L, Cogswell ME. Prevalence of excess sodium intake in the United States—NHANES, 2009–2012. MMWR Morb Mortal Wkly Rep. 2016;64(52):1393–7.

0. 287.  He FJ, Li J, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013;(4):CD004937.

0. 288.  Semlitsch T, Jeitler K, Berghold A, et al. Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database Syst Rev. 2016;3:CD008274.

0. 289.  Gulland A. Three in four are unaware of obesity link to cancer, says charity. BMJ. 2016;354:i4898.

0. 290.  Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer—viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794–8.

0. 291.  Kolb R, Sutterwala FS, Zhang W. Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol. 2016;29:77–89.

0. 292.  Poloz Y, Stambolic V. Obesity and cancer, a case for insulin signaling. Cell Death Dis. 2015;6:e2037.

0. 293.  O’Rourke RW. Obesity and cancer: at the crossroads of cellular metabolism and proliferation. Surg Obes Relat Dis. 2014;10(6):1208–19.

0. 294.  Cleland WH, Mendelson CR, Simpson ER. Effects of aging and obesity on aromatase activity of human adipose cells. J Clin Endocrinol Metab. 1985;60(1):174–7.

0. 295.  Cauley JA, Gutai JP, Kuller LH, Ledonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol. 1989;129(6):1120–31.

0. 296.  Goodwin PJ, Stambolic V. Impact of the obesity epidemic on cancer. Annu Rev Med. 2015;66:281–96.

0. 297.  Carpenter CL, Duvall K, Jardack P, et al. Weight loss reduces breast ductal fluid estrogens in obese postmenopausal women: a single arm intervention pilot study. Nutr J. 2012;11:102.

0. 298.  Zhang X, Zhou G, Sun B, et al. Impact of obesity upon prostate cancer-associated mortality: a meta-analysis of 17 cohort studies. Oncol Lett. 2015;9(3):1307–12.

0. 299.  Barnes KT, McDowell BD, Button A, Smith BJ, Lynch CF, Gupta A. Obesity is associated with increased risk of invasive penile cancer. BMC Urol. 2016;16(1):42.

0. 300.  Sjöström L, Gummesson A, Sjöström CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653–62.

0. 301.  Tao W, Konings P, Hull MA, Adami HO, Mattsson F, Lagergren J. Colorectal cancer prognosis following obesity surgery in a population-based cohort study. Obes Surg. 2017;27(5):1233–9.

0. 302.  Tao W, Konings P, Hull MA, Adami HO, Mattsson F, Lagergren J. Colorectal cancer prognosis following obesity surgery in a population-based cohort study. Obes Surg. 2017;27(5):1233–9.

0. 303.  Kant P, Sainsbury A, Reed KR, et al. Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB. Gut. 2011;60(7):893–901.

0. 304.  Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med. 2007;24(5):451–63.

0. 305.  Centers for Disease Control and Prevention. About diabetes. CDC.gov. Published June 1, 2017. Available at: https://www.cdc.gov/diabetes/basics/diabetes.html. Accessed March 22, 2019.

0. 306.  Lau DC, Teoh H. Impact of current and emerging glucose-lowering drugs on body weight in type 2 diabetes. Can J Diabetes. 2015;39 Suppl 5:S148–54.

0. 307.  Pedditzi E, Peters R, Beckett N. The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. Age Ageing. 2016;45(1):14–21.

0. 308.  Loef M, Walach H. Midlife obesity and dementia: meta-analysis and adjusted forecast of dementia prevalence in the United States and China. Obesity (Silver Spring). 2013;21(1):E51–5.

0. 309.  Yang Y, Shields GS, Guo C, Liu Y. Executive function performance in obesity and overweight individuals: a meta-analysis and review. Neurosci Biobehav Rev. 2018;84:225–44.

0. 310.  McCrady-Spitzer SK, Levine JA. Nonexercise activity thermogenesis: a way forward to treat the worldwide obesity epidemic. Surg Obes Relat Dis. 2012;8(5):501–6.

0. 311.  Willette AA, Kapogiannis D. Does the brain shrink as the waist expands? Ageing Res Rev. 2015;20:86–97.

0. 312.  Walther K, Birdsill AC, Glisky EL, Ryan L. Structural brain differences and cognitive functioning related to body mass index in older females. Hum Brain Mapp. 2010;31(7):1052–64.

0. 313.  Kullmann S, Schweizer F, Veit R, Fritsche A, Preissl H. Compromised white matter integrity in obesity. Obes Rev. 2015;16(4):273–81.

0. 314.  Yang Y, Shields GS, Guo C, Liu Y. Executive function performance in obesity and overweight individuals: a meta-analysis and review. Neurosci Biobehav Rev. 2018;84:225–44.

0. 315.  Veronese N, Facchini S, Stubbs B, et al. Weight loss is associated with improvements in cognitive function among overweight and obese people: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2017;72:87–94.

0. 316.  Veronese N, Facchini S, Stubbs B, et al. Weight loss is associated with improvements in cognitive function among overweight and obese people: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2017;72:87–94.

0. 317.  Best D, Avenell A, Bhattacharya S. How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence. Hum Reprod Update. 2017;23(6):681–705.

0. 318.  Sermondade N, Faure C, Fezeu L, et al. BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Hum Reprod Update. 2013;19(3):221–31.

0. 319.  Davidson LM, Millar K, Jones C, Fatum M, Coward K. Deleterious effects of obesity upon the hormonal and molecular mechanisms controlling spermatogenesis and male fertility. Hum Fertil (Camb). 2015;18(3):184–93.

0. 320.  Eriksson J, Haring R, Grarup N, et al. Causal relationship between obesity and serum testosterone status in men: a bi-directional Mendelian randomization analysis. PLoS ONE. 2017;12(4):e0176277.

0. 321.  Cavayero CT, Cooper MA, Harlin SL. Adult-acquired hidden penis in obese patients: a critical survey of the literature. J Am Osteopath Assoc. 2015;115(3):150–6.

0. 322.  Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230–9.

0. 323.  Alexander HC, Bartlett AS, Wells CI, et al. Reporting of complications after laparoscopic cholecystectomy: a systematic review. HPB (Oxford). 2018;20(9):786–94.

0. 324.  Pucher PH, Brunt LM, Davies N, et al. Outcome trends and safety measures after 30 years of laparoscopic cholecystectomy: a systematic review and pooled data analysis. Surg Endosc. 2018;32(5):2175–83.

0. 325.  Isherwood J, Oakland K, Khanna A. A systematic review of the aetiology and management of post cholecystectomy syndrome. Surgeon. 2019;17(1):33–42.

0. 326.  Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230–9.

0. 327.  Pradhan SB, Joshi MR, Vaidya A. Prevalence of different types of gallstone in the patients with cholelithiasis at Kathmandu Medical College, Nepal. Kathmandu Univ Med J (KUMJ). 2009;7(27):268–71.

0. 328.  McConnell TJ, Appleby PN, Key TJ. Vegetarian diet as a risk factor for symptomatic gallstone disease. Eur J Clin Nutr. 2017;71(6):731–5.

0. 329.  Chang CM, Chiu THT, Chang CC, Lin MN, Lin CL. Plant-based diet, cholesterol, and risk of gallstone disease: a prospective study. Nutrients. 2019;11(2):335.

0. 330.  Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology. 2013;58(6):2133–41.

0. 331.  Cruz-Monserrate Z, Conwell DL, Krishna SG. The impact of obesity on gallstone disease, acute pancreatitis, and pancreatic cancer. Gastroenterol Clin North Am. 2016;45(4):625–37.

0. 332.  Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55(3):652–8.

0. 333.  Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med. 1995;98(2):115–7.

0. 334.  Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Long-term intake of dietary fiber and decreased risk of cholecystectomy in women. Am J Gastroenterol. 2004;99(7):1364–70.

0. 335.  Sulaberidze G, Okujava M, Liluashvili K, Tughushi M, Bezarashvili S. Dietary fiber’s benefit for gallstone disease prevention during rapid weight loss in obese patients. Georgian Med News. 2014;(231):95–9.

0. 336.  Hampel H, Abraham N, El-Serag H. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211.

0. 337.  Giri A, Hartmann KE, Hellwege JN, Velez Edwards DR, Edwards TL. Obesity and pelvic organ prolapse: a systematic review and meta-analysis of observational studies. Am J Obstet Gynecol. 2017;217(1):11–26.e3.

0. 338.  Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.

0. 339.  Hägg S, Fall T, Ploner A, et al. Adiposity as a cause of cardiovascular disease: a Mendelian randomization study. Int J Epidemiol. 2015;44(2):578–86.

0. 340.  Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.

0. 341.  Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.

0. 342.  Jahn J, Spielau M, Brandsch C, et al. Decreased NK cell functions in obesity can be reactivated by fat mass reduction. Obesity (Silver Spring). 2015;23(11):2233–41.

0. 343.  Walsh NP, Gleeson M, Shephard RJ, et al. Position statement. Part one: immune function and exercise. Exerc Immunol Rev. 2011;17:6–63.

0. 344.  Mokry LE, Ross S, Timpson NJ, Sawcer S, Davey Smith G, Richards JB. Obesity and multiple sclerosis: a Mendelian randomization study. PLoS Med. 2016;13(6):e1002053.

0. 345.  Chen S, Akbar SM, Miyake T, et al. Diminished immune response to vaccinations in obesity: role of myeloid-derived suppressor and other myeloid cells. Obes Res Clin Pract. 2015;9(1):35–44.

0. 346.  Gallacher J, McPherson S. Practical diagnosis and staging of nonalcoholic fatty liver disease: a narrative review. EMJ. 2018;3(2):108–18.

0. 347.  Gallacher J, McPherson S. Practical diagnosis and staging of nonalcoholic fatty liver disease: a narrative review. EMJ. 2018;3(2):108–18.

0. 348.  Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142(7):1592–609.

0. 349.  Calzadilla Bertot L, Adams LA. The natural course of non-alcoholic fatty liver disease. Int J Mol Sci. 2016;17(5):774.

0. 350.  Noureddin M, Vipani A, Bresee C, et al. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances. Am J Gastroenterol. 2018;113(11):1649–59.

0. 351.  Kovesdy CP, Furth SL, Zoccali C. Obesity and kidney disease: hidden consequences of the epidemic. Am J Nephrol. 2017;45:283–91.

0. 352.  Forno E, Han YY, Mullen J, Celedón JC. Overweight, obesity, and lung function in children and adults—a meta-analysis. J Allergy Clin Immunol Pract. 2018;6(2):570–81.e10.

0. 353.  Zafar U, Khaliq S, Ahmad HU, Manzoor S, Lone KP. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links. Hormones (Athens). 2018;17(3):299–313.

0. 354.  Hogerzeil DP, Hartholt KA, de Vries MR. Xiphoidectomy: a surgical intervention for an underdocumented disorder. Case Rep Surg. 2016;2016:9306262.

0. 355.  Kim DD, Basu A. Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis. Value Health. 2016;19(5):602–13.

0. 356.  Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G. Lifetime health and economic consequences of obesity. Arch Intern Med. 1999;159(18):2177–83.

0. 357.  Bhattacharya J, Bundorf MK. The incidence of the healthcare costs of obesity. J Health Econ. 2009;28(3):649–58.

0. 358.  Hamilton D, Dee A, Perry IJ. The lifetime costs of overweight and obesity in childhood and adolescence: a systematic review. Obes Rev. 2018;19(4):452–63.

0. 359.  Kim DD, Basu A. Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis. Value Health. 2016;19(5):602–13.

0. 360.  Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815–25.

0. 361.  Waters H, DeVol R. Weighing down America: the health and economic impact of obesity. Milken Institute. Published November 2016. Available at: https://assets1b.milkeninstitute.org/assets/publication/researchreport/pdf/weighing-down-america-web.pdf. Accessed March 21, 2019.

0. 362.  Under Secretary of Defense (Comptroller), Chief Financial Officer. Defense Budget Overview. United States Department of Defense. Published May 12, 2017. Available at: https://comptroller.defense.gov/portals/45/documents/defbudget/fy2018/fy2018_budget_request_overview_book.pdf. Accessed March 22, 2019.

0. 363.  van Baal PH, Polder JJ, de Wit GA, et al. Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med. 2008;5(2):e29.

0. 364.  King, ML Jr. Stride Toward Freedom: The Montgomery Story. New York: Harper; 1958.

0. 365.  Mathers JC. Obesity and mortality: is childhood obesity shortening life expectancy? Maturitas. 2015;81(1):1–2.

0. 366.  Ludwig DS. Lifespan weighed down by diet. JAMA. 2016;315(21):2269–70.

0. 367.  Mathers JC. Obesity and mortality: is childhood obesity shortening life expectancy? Maturitas. 2015;81(1):1–2.

0. 368.  Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352(11):1138–45.

0. 369.  Ludwig DS. Lifespan weighed down by diet. JAMA. 2016;315(21):2269–70.

0. 370.  Mann CC. Public health. Provocative study says obesity may reduce U.S. life expectancy. Science. 2005;307(5716):1716–7.

0. 371.  Tobias DK, Hu FB. Does being overweight really reduce mortality? Obesity (Silver Spring). 2013;21(9):1746–9.

0. 372.  Fryar CD, Gu Q, Ogden CL, Flegal KM. Anthropometric reference data for children and adults: United States, 2011–2014. Vital Health Stat 3. 2016;(39):1–46.

0. 373.  Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82.

0. 374.  National Health Service. Overweight people “live longer” study claims. NHS.uk. Published January 2, 2013. Available at: https://www.nhs.uk/news/obesity/overweight-people-live-longer-study-claims. Accessed March 21, 2019.

0. 375.  Beck M. A few extra pounds won’t kill you—really. Wall Street Journal. Published January 1, 2013. Available at: https://www.wsj.com/articles/SB10001424127887323635504578215801377387088. Accessed March 21, 2019.

0. 376.  Aubrey A. Research: a little extra fat may help you live longer. National Public Radio. Published January 2, 2013. Available at: https://www.npr.org/sections/health-shots/2013/01/02/168437030/research-a-little-extra-fat-may-help-you-live-longer. Accessed March 21, 2019.

0. 377.  Hughes V. The big fat truth. Nature. Published May 22, 2013. Available at: https://www.nature.com/news/the-big-fat-truth-1.13039. Accessed March 21, 2019.

0. 378.  Aubrey A. Research: a little extra fat may help you live longer. National Public Radio. Published January 2, 2013. Available at: https://www.npr.org/sections/health-shots/2013/01/02/168437030/research-a-little-extra-fat-may-help-you-live-longer. Accessed March 21, 2019.

0. 379.  Hughes V. The big fat truth. Nature. Published May 22, 2013. Available at: https://www.nature.com/news/the-big-fat-truth-1.13039. Accessed March 21, 2019.

0. 380.  Flegal KM, Ioannidis JPA. The obesity paradox: a misleading term that should be abandoned. Obesity (Silver Spring). 2018;26(4):629–30.

0. 381.  Stokes A, Preston SH. Smoking and reverse causation create an obesity paradox in cardiovascular disease. Obesity (Silver Spring). 2015;23(12):2485–90.

0. 382.  Hennekens CH, Andreotti F. Leading avoidable cause of premature deaths worldwide: case for obesity. Am J Med. 2013;126(2):97–8.

0. 383.  Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med. 1999;341(6):427–34.

0. 384.  National Center for Health Statistics. Trend Tables, National Health and Nutrition Examination Survey. Appendix I. Centers for Disease Control and Prevention. Published August 9, 2018. Available at: https://www.cdc.gov/nchs/hus/contents2017.htm#053. Accessed March 18, 2019.

0. 385.  Willett WC, Hu FB, Thun M. Overweight, obesity, and all-cause mortality. JAMA. 2013;309(16):1681.

0. 386.  Berrigan D, Troiano RP, Graubard BI. BMI and mortality: the limits of epidemiological evidence. Lancet. 2016;388(10046):734–6.

0. 387.  Di Angelantonio E, Bhupathiraju SN, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–86.

0. 388.  Stokes A, Preston SH. Smoking and reverse causation create an obesity paradox in cardiovascular disease. Obesity (Silver Spring). 2015;23(12):2485–90.

0. 389.  Obesity paradox? Just a myth. Harv Heart Lett. 2014;24(8):8.

0. 390.  Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–7.

0. 391.  Kritchevsky SB, Beavers KM, Miller ME, et al. Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials. PLoS ONE. 2015;10(3):e0121993.

0. 392.  Barry VW, Caputo JL, Kang M. The joint association of fitness and fatness on cardiovascular disease mortality: a meta-analysis. Prog Cardiovasc Dis. 2018;61(2):136–41.

0. 393.  Shea MK, Houston DK, Nicklas BJ, et al. The effect of randomization to weight loss on total mortality in older overweight and obese adults: the ADAPT Study. J Gerontol A Biol Sci Med Sci. 2010;65(5):519–25.

0. 394.  Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211–9.

0. 395.  Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.

0. 396.  Aune D, Sen A, Prasad M, et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 2016;353:i2156.

0. 397.  Fontana L, Hu FB. Optimal body weight for health and longevity: bridging basic, clinical, and population research. Aging Cell. 2014;13(3):391–400.

0. 398.  Thorogood M, Appleby PN, Key TJ, Mann J. Relation between body mass index and mortality in an unusually slim cohort. J Epidemiol Community Health. 2003;57(2):130–3.

0. 399.  Kitahara CM, Flint AJ, Berrington de Gonzalez A, et al. Association between class III obesity (BMI of 40–59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med. 2014;11(7):e1001673.

0. 400.  Gard M. Truth, belief and the cultural politics of obesity scholarship and public health policy. Crit Public Health. 2011;21(1):37–48.

0. 401.  Saguy AC, Riley KW. Weighing both sides: morality, mortality, and framing contests over obesity. J Health Polit Policy Law. 2005;30(5):869–921.

0. 402.  Saguy AC, Riley KW. Weighing both sides: morality, mortality, and framing contests over obesity. J Health Polit Policy Law. 2005;30(5):869–921.

0. 403.  Gurrieri L, Cherrier H. Queering beauty: fatshionistas in the fatosphere. Qual Market Res Int J. 2013;16(3):276–95.

0. 404.  Santos-Lozano A, Pareja-Galeano H, Fuku N, et al. Implications of obesity in exceptional longevity. Ann Transl Med. 2016;4(20):416.

0. 405.  Brown RE, Kuk JL. Consequences of obesity and weight loss: a devil’s advocate position. Obes Rev. 2015;16(1):77–87.

0. 406.  Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–69.

0. 407.  Appleton SL, Seaborn CJ, Visvanathan R, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36(8):2388–94.

0. 408.  Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev. 2014;15(6):504–15.

0. 409.  Chang Y, Jung HS, Cho J, et al. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am J Gastroenterol. 2016;111(8):1133–40.

0. 410.  Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–69.

0. 411.  Hill JO, Wyatt HR. The myth of healthy obesity. Ann Intern Med. 2013;159(11):789–90.

0. 412.  Puhl R, Brownell KD. Bias, discrimination, and obesity. Obes Res. 2001;9(12):788–805.

0. 413.  Seacat JD, Dougal SC, Roy D. A daily diary assessment of female weight stigmatization. J Health Psychol. 2016;21(2):228–40.

0. 414.  Puhl RM, Andreyeva T, Brownell KD. Perceptions of weight discrimination: prevalence and comparison to race and gender discrimination in America. Int J Obes (Lond). 2008;32(6):992–1000.

0. 415.  Cramer P, Steinwert T. Thin is good, fat is bad: how early does it begin? J Appl Dev Psychol. 1998;19(3):429–51.

0. 416.  Richardson S, Goodman N, Hastorf A, Dornbusch S. Cultural uniformity in reaction to physical disabilities. Am Sociol Rev. 1961;26(2):241.

0. 417.  Latner JD, Stunkard AJ. Getting worse: the stigmatization of obese children. Obes Res. 2003;11(3):452–6.

0. 418.  Andreyeva T, Puhl RM, Brownell KD. Changes in perceived weight discrimination among Americans, 1995–1996 through 2004–2006. Obesity (Silver Spring). 2008;16(5):1129–34.

0. 419.  Neumark-Sztainer D, Story M, Harris T. Beliefs and attitudes about obesity among teachers and school health care providers working with adolescents. J Nutr Educ Behav. 1999;31(1):3–9.

0. 420.  Crandall C. Do parents discriminate against their heavyweight daughters? Pers Soc Psychol Bull. 1995;21(7):724–35.

0. 421.  Puhl R, Brownell KD. Bias, discrimination, and obesity. Obes Res. 2001;9(12):788–805.

0. 422.  Foster GD, Wadden TA, Makris AP, et al. Primary care physicians’ attitudes about obesity and its treatment. Obes Res. 2003;11(10):1168–77.

0. 423.  Bagley CR, Conklin DN, Isherwood RT, Pechiulis DR, Watson LA. Attitudes of nurses toward obesity and obese patients. Percept Mot Skills. 1989;68(3 Pt 1):954.

0. 424.  Poorolajal J, Jenabi E. The association between BMI and cervical cancer risk: a meta-analysis. Eur J Cancer Prev. 2016;25(3):232–8.

0. 425.  Adams CH, Smith NJ, Wilbur DC, Grady KE. The relationship of obesity to the frequency of pelvic examinations: do physician and patient attitudes make a difference? Women Health. 1993;20(2):45–57.

0. 426.  Hernandez-Boussard T, Ahmed SM, Morton JM. Obesity disparities in preventive care: findings from the National Ambulatory Medical Care Survey, 2005–2007. Obesity (Silver Spring). 2012;20(8):1639–44.

0. 427.  LaMendola B. Overweight women: some ob-gyns in South Florida turn away overweight women. Sun Sentinel. Published May 16, 2011. Available at: http://articles.sun-sentinel.com/2011-05-16/health/fl-hk-no-obesity-doc-20110516_1_gyn-ob-gyn-obese-patients. Accessed April 17, 2019.

0. 428.  Hebl MR, Xu J. Weighing the care: physicians’ reactions to the size of a patient. Int J Obes Relat Metab Disord. 2001;25(8):1246–52.

0. 429.  Gudzune KA, Beach MC, Roter DL, Cooper LA. Physicians build less rapport with obese patients. Obesity (Silver Spring). 2013;21(10):2146–52.

0. 430.  Gudzune KA, Huizinga MM, Beach MC, Cooper LA. Obese patients overestimate physicians’ attitudes of respect. Patient Educ Couns. 2012;88(1):23–8.

0. 431.  Sutin AR, Terracciano A. Perceived weight discrimination and obesity. PLoS ONE. 2013;8(7):e70048.

0. 432.  Vartanian LR, Novak SA. Internalized societal attitudes moderate the impact of weight stigma on avoidance of exercise. Obesity (Silver Spring). 2011;19(4):757–62.

0. 433.  Ball K, Crawford D, Owen N. Too fat to exercise? Obesity as a barrier to physical activity. Aust N Z J Public Health. 2000;24(3):331–3.

0. 434.  Robertson N, Vohora R. Fitness vs. fatness: implicit bias towards obesity among fitness professionals and regular exercisers. Psychol Sport Exerc. 2008;9(4):547–57.

0. 435.  Vartanian LR, Novak SA. Internalized societal attitudes moderate the impact of weight stigma on avoidance of exercise. Obesity (Silver Spring). 2011;19(4):757–62.

0. 436.  Robinson E, Sutin A, Daly M. Perceived weight discrimination mediates the prospective relation between obesity and depressive symptoms in U.S. and U.K. adults. Health Psychol. 2017;36(2):112–21.

0. 437.  Sutin AR, Stephan Y, Luchetti M, Terracciano A. Perceived weight discrimination and C-reactive protein. Obesity (Silver Spring). 2014;22(9):1959–61.

0. 438.  Tomiyama AJ, Epel ES, McClatchey TM, et al. Associations of weight stigma with cortisol and oxidative stress independent of adiposity. Health Psychol. 2014;33(8):862–7.

0. 439.  Sutin AR, Stephan Y, Terracciano A. Weight discrimination and risk of mortality. Psychol Sci. 2015;26(11):1803–11.

0. 440.  Callahan D. Obesity: chasing an elusive epidemic. Hastings Cent Rep. 2013;43(1):34–40.

0. 441.  Puhl R, Luedicke J, Lee Peterson J. Public reactions to obesity-related health campaigns: a randomized controlled trial. Am J Prev Med. 2013;45(1):36–48.

0. 442.  Grinberg E. Georgia’s child obesity ads aim to create movement out of controversy. CNN. Published February 7, 2012. Available at: https://www.cnn.com/2012/02/07/health/atlanta-child-obesity-ads/index.html. Accessed April 17, 2019.

0. 443.  Hunger JM, Tomiyama AJ. Weight labeling and obesity: a longitudinal study of girls aged 10 to 19 years. JAMA Pediatr. 2014;168(6):579–80.

0. 444.  Churchill J, Ward E. Communicating with pet owners about obesity: roles of the veterinary health care team. Vet Clin North Am Small Anim Pract. 2016;46(5):899–911.

0. 445.  Perrin EM, Skinner AC, Steiner MJ. Parental recall of doctor communication of weight status: national trends from 1999 through 2008. Arch Pediatr Adolesc Med. 2012;166(4):317–22.

0. 446.  Callahan D. Obesity: chasing an elusive epidemic. Hastings Cent Rep. 2013;43(1):34–40.

0. 447.  Rose SA, Poynter PS, Anderson JW, Noar SM, Conigliaro J. Physician weight loss advice and patient weight loss behavior change: a literature review and meta-analysis of survey data. Int J Obes (Lond). 2013;37(1):118–28.

0. 448.  Pool AC, Kraschnewski JL, Cover LA, et al. The impact of physician weight discussion on weight loss in US adults. Obes Res Clin Pract. 2014;8(2):e131–9.

0. 449.  Bleich SN, Bennett WL, Gudzune KA, Cooper LA. Impact of physician BMI on obesity care and beliefs. Obesity (Silver Spring). 2012;20(5):999–1005.

0. 450.  Berry AC, Berry NA, Myers TS, Reznicek J, Berry BB. Physician body mass index and bias toward obesity documentation patterns. Ochsner J. 2018;18(1):66–71.

0. 451.  Bleich SN, Gudzune KA, Bennett WL, Jarlenski MP, Cooper LA. How does physician BMI impact patient trust and perceived stigma? Prev Med. 2013;57(2):120–4.

0. 452.  Kraschnewski JL, Sciamanna CN, Stuckey HL, et al. A silent response to the obesity epidemic: decline in US physician weight counseling. Med Care. 2013;51(2):186–92.

0. 453.  Smith AW, Borowski LA, Liu B, et al. U.S. primary care physicians’ diet-, physical activity-, and weight-related care of adult patients. Am J Prev Med. 2011;41(1):33–42.

0. 454.  Foster GD, Wadden TA, Makris AP, et al. Primary care physicians’ attitudes about obesity and its treatment. Obes Res. 2003;11(10):1168–77.

0. 455.  Adler NE, Stewart J. Reducing obesity: motivating action while not blaming the victim. Milbank Q. 2009;87(1):49–70.

0. 456.  Tomiyama AJ, Mann T. If shaming reduced obesity, there would be no fat people. Hastings Cent Rep. 2013;43(3):4–5.

0. 457.  Rand CS, MacGregor AM. Successful weight loss following obesity surgery and the perceived liability of morbid obesity. Int J Obes. 1991;15(9):577–9.

0. 458.  Wright B. Sensitizing outsiders to the position of the insider. Rehabil Psychol. 1975;22(2):129–35.

0. 459.  Rand CS, Macgregor AM. Successful weight loss following obesity surgery and the perceived liability of morbid obesity. Int J Obes. 1991;15(9):577–9.

0. 460.  Pellagra: secondary to antiobesity diet. Postgrad Med. 1955;17(3):37.

0. 461.  Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.

0. 462.  Zheng Y, Manson JE, Yuan C, et al. Associations of weight gain from early to middle adulthood with major health outcomes later in life. JAMA. 2017;318(3):255–69.

0. 463.  Chaston TB, Dixon JB. Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes (Lond). 2008;32(4):619–28.

0. 464.  Warkentin LM, Majumdar SR, Johnson JA, et al. Weight loss required by the severely obese to achieve clinically important differences in health-related quality of life: two-year prospective cohort study. BMC Med. 2014;12:175.

0. 465.  Williamson DA, Bray GA, Ryan DH. Is 5% weight loss a satisfactory criterion to define clinically significant weight loss? Obesity (Silver Spring). 2015;23(12):2319–20.

0. 466.  Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102–7.

0. 467.  Mackie GM, Samocha-Bonet D, Tam CS. Does weight cycling promote obesity and metabolic risk factors? Obes Res Clin Pract. 2017;11(2):131–9.

0. 468.  Mehta T, Smith DL, Muhammad J, Casazza K. Impact of weight cycling on risk of morbidity and mortality. Obes Rev. 2014;15(11):870–81.

0. 469.  Brownell KD, Greenwood MR, Stellar E, Shrager EE. The effects of repeated cycles of weight loss and regain in rats. Physiol Behav. 1986;38(4):459–64.

0. 470.  Mehta T, Smith DL, Muhammad J, Casazza K. Impact of weight cycling on risk of morbidity and mortality. Obes Rev. 2014;15(11):870–81.

0. 471.  Smith DL, Yang Y, Nagy TR, et al. Weight cycling increases longevity compared with sustained obesity in mice. Obesity (Silver Spring). 2018;26(11):1733–9.

0. 472.  Syngal S, Coakley EH, Willett WC, Byers T, Williamson DF, Colditz GA. Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med. 1999;130(6):471–7.

0. 473.  Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Weight cycling and risk of gallstone disease in men. Arch Intern Med. 2006;166(21):2369–74.

0. 474.  Mehta T, Smith DL, Muhammad J, Casazza K. Impact of weight cycling on risk of morbidity and mortality. Obes Rev. 2014;15(11):870–81.

0. 475.  Di Germanio C, Di Francesco A, Bernier M, de Cabo R. Yo-yo dieting is better than none. Obesity (Silver Spring). 2018;26(11):1673.

0. 476.  Afshin A, Reitsma MB, Murray CJL. Health effects of overweight and obesity in 195 countries. N Engl J Med. 2017;377(15):1496–7.

0. 477.  Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008;32(6):959–66.

0. 478.  Ortega FB, Sui X, Lavie CJ, Blair SN. Body mass index, the most widely used but also widely criticized index: would a criterion standard measure of total body fat be a better predictor of cardiovascular disease mortality? Mayo Clin Proc. 2016;91(4):443–55.

0. 479.  Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008;32(6):959–66.

0. 480.  Dickey RA, Bartuska DG, Bray GW, et al. AACE/ACE position statement on the prevention, diagnosis, and treatment of obesity (1998 revision). Endocr Pract. 1998;4(5):300–30.

0. 481.  Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015;50(3):117–28.

0. 482.  Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jimenez F. The concept of normal weight obesity. Prog Cardiovasc Dis. 2014;56(4):426–33.

0. 483.  Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008;32(6):959–66.

0. 484.  Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008;32(6):959–66.

0. 485.  Ortega FB, Sui X, Lavie CJ, Blair SN. Body mass index, the most widely used but also widely criticized index: would a criterion standard measure of total body fat be a better predictor of cardiovascular disease mortality? Mayo Clin Proc. 2016;91(4):443–55.

0. 486.  Wells JC. Commentary: the paradox of body mass index in obesity assessment: not a good index of adiposity, but not a bad index of cardio-metabolic risk. Int J Epidemiol. 2014;43(3):672–4.

0. 487.  Gwartney D, Allison A,
Pastuszak AW, et al. MP47-17: rates of mortality are higher among professional male bodybuilders. J Urology. 2016;195(4S):e633.

0. 488.  Frati P, Busardò FP, Cipolloni L, Dominicis ED, Fineschi V. Anabolic androgenic steroid (AAS) related deaths: autoptic, histopathological and toxicological findings. Curr Neuropharmacol. 2015;13(1):146–59.

0. 489.  Schemmel R, Vaghefi S, Bowman B. Olaf Mickelsen (July 29, 1912 to August 8, 1999). J Nutr. 2001;131(2):205–10.

0. 490.  Blackburn H, Jacobs D. Commentary: origins and evolution of body mass index (BMI): continuing saga. Int J Epidemiol. 2014;43(3):665–9.

0. 491.  Smith U. Abdominal obesity: a marker of ectopic fat accumulation. J Clin Invest. 2015;125(5):1790–2.

0. 492.  Flegal KM, Graubard BI. Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr. 2009;89(4):1213–9.

0. 493.  Cerhan JR, Moore SC, Jacobs EJ, et al. A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc. 2014;89(3):335–45.

0. 494.  Sahakyan KR, Somers VK, Rodriguez-Escudero JP, et al. Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med. 2015;163(11):827–35.

0. 495.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii,1–253.

0. 496.  Working group of the North American Association for the Study of Obesity, National Heart, Lung, and Blood Institute, and the American Society for Bariatric Surgery. Practical guide to the identification, evaluation and treatment of overweight and obesity in adults. National Institutes of Health. Published October 2000. Available at: https://www.nhlbi.nih.gov/files/docs/guidelines/prctgd_c.pdf. Accessed March 21, 2019.

0. 497.  Rao G, Powell-Wiley TM, Ancheta I, et al. Identification of obesity and cardiovascular risk in ethnically and racially diverse populations: a scientific statement from the American Heart Association. Circulation. 2015;132(5):457–72.

0. 498.  Rubin R. Postmenopausal women with a “normal” BMI might be overweight or even obese. JAMA. 2018;319(12):1185–7.

0. 499.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii,1–253.

0. 500.  IDF Task Force on Epidemiology and Prevention Writing Group. The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation. Published 2006. Available at: https://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome. Accessed March 21, 2019.

0. 501.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii,1–253.

0. 502.  Cerhan JR, Moore SC, Jacobs EJ, et al. A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc. 2014;89(3):335–45.

0. 503.  Brown RE, Randhawa AK, Canning KL, et al. Waist circumference at five common measurement sites in normal weight and overweight adults: which site is most optimal? Clin Obes. 2018;8(1):21–9.

0. 504.  Brown RE, Randhawa AK, Canning KL, et al. Waist circumference at five common measurement sites in normal weight and overweight adults: which site is most optimal? Clin Obes. 2018;8(1):21–9.

0. 505.  Shi W, Neubeck L, Gallagher R. Measurement matters: a systematic review of waist measurement sites for determining central adiposity. Collegian. 2016;24(5):513–23.

0. 506.  Swainson MG, Batterham AM, Tsakirides C, Rutherford ZH, Hind K. Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables. PLoS ONE. 2017;12(5):e0177175.

0. 507.  Yoo EG. Waist-to-height ratio as a screening tool for obesity and cardiometabolic risk. Korean J Pediatr. 2016;59(11):425–31.

0. 508.  Swainson MG, Batterham AM, Tsakirides C, Rutherford ZH, Hind K. Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables. PLoS ONE. 2017;12(5):e0177175.

0. 509.  Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275–86.

0. 510.  Martin-Calvo N, Moreno-Galarraga L, Martinez-Gonzalez MA. Association between body mass index, waist-to-height ratio and adiposity in children: a systematic review and meta-analysis. Nutrients. 2016;8(8):512.

0. 511.  Carmienke S, Freitag MH, Pischon T, et al. General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis. Eur J Clin Nutr. 2013;67(6):573–85.

0. 512.  Frank A. Futility and avoidance: medical professionals in the treatment of obesity. JAMA. 1993;269(16):2132–3.

0. 513.  Astwood EB. The heritage of corpulence. Endocrinology. 1962;71:337–41.

0. 514.  Garrow JS. Treatment of obesity. Lancet. 1992;340(8816):409–13.

0. 515.  Frank A. Futility and avoidance: medical professionals in the treatment of obesity. JAMA. 1993;269(16):2132–3.

0. 516.  Chaiton M, Diemert L, Cohen JE, et al. Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers. BMJ Open. 2016;6(6):e011045.

0. 517.  Garrow JS. Treatment of obesity. Lancet. 1992;340(8816):409–13.

0. 518.  Vallgårda S. Childhood obesity policies—mighty concerns, meek reactions. Obes Rev. 2018;19(3):295–301.

0. 519.  Vallgårda S. Childhood obesity policies—mighty concerns, meek reactions. Obes Rev. 2018;19(3):295–301.

0. 520.  Biltekoff C. The terror within: obesity in post 9/11 U.S. life. American Studies. 2007;48(3):29–48.

0. 521.  European Commission. EU action plan on childhood obesity 2014-2020. EC.Europa.eu. Published February 24, 2014. Available at: https://ec.europa.eu/health/sites/health/files/nutrition_physical_activity/docs/childhoodobesity_actionplan_2014_2020_en.pdf. Accessed March 21, 2019.

0. 522.  Hill JO. Can a small-changes approach help address the obesity epidemic? A report of the Joint Task Force of the American Society for Nutrition, Institute of Food Technologists, and International Food Information Council. Am J Clin Nutr. 2009;89(2):477–84.

0. 523.  Hill JO. Can a small-changes approach help address the obesity epidemic? A report of the Joint Task Force of the American Society for Nutrition, Institute of Food Technologists, and International Food Information Council. Am J Clin Nutr. 2009;89(2):477–84.

0. 524.  Guth E. Counting calories as an approach to achieve weight control. JAMA. 2018;319(3):225–6.

0. 525.  Guth E. Counting calories as an approach to achieve weight control. JAMA. 2018;319(3):225–6.

0. 526.  Sterodimas A, Boriani F, Magarakis E, Nicaretta B, Pereira LH, Illouz YG. Thirtyfour years of liposuction: past, present and future. Eur Rev Med Pharmacol Sci. 2012;16(3):393–406.

0. 527.  Grazer FM, De jong RH. Fatal outcomes from liposuction: census survey of cosmetic surgeons. Plast Reconstr Surg. 2000;105(1):436–46.

0. 528.  Bellini E, Grieco MP, Raposio E. A journey through liposuction and liposculture: review. Ann Med Surg (Lond). 2017;24:53–60.

0. 529.  Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350(25):2549–57.

0. 530.  Blackburn G. Effect of degree of weight loss on health benefits. Obes Res. 1995;3 Suppl 2:211s–6s.

0. 531.  Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350(25):2549–57.

0. 532.  Scopinaro N. The IFSO and obesity surgery throughout the world. Obes Surg. 1998;8(1):3–8.

0. 533.  American Society for Metabolic and Bariatric Surgery. Estimate of bariatric surgery numbers, 2011–2017. ASMBS.org. Published June 2018. Available at: https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers. Accessed March 21, 2019.

0. 534.  DiBaise J, Parrish C, Thompson J. Short Bowel Syndrome: Practical Approach to Management. 1st ed. Boca Raton, FL: CRC Press; 2016.

0. 535.  Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S89–96.

0. 536.  Celio AC, Pories WJ. A history of bariatric surgery: the maturation of a medical discipline. Surg Clin North Am. 2016;96(4):655–67.

0. 537.  Dixon JB, Logue J, Komesaroff PA. Promises and ethical pitfalls of surgical innovation: the case of bariatric surgery. Obes Surg. 2013;23(10):1698–702.

0. 538.  Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S89–96.

0. 539.  Celio AC, Pories WJ. A history of bariatric surgery: the maturation of a medical discipline. Surg Clin North Am. 2016;96(4):655–67.

0. 540.  Drenick EJ, Simmons F, Murphy JF. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med. 1970;282(15):829–34.

0. 541.  Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S89–96.

0. 542.  Dartmouth Atlas Working Group. Variation in the care of surgical conditions: obesity. Dartmouth Institute for Health Policy & Clinical Practice. Published September 2014. Available at: https://www.researchgate.net/publication/283298425_Variation_in_the_Care_of_Surgical_Conditions_Obesity. Accessed March 21, 2019.

0. 543.  Cardoso L, Rodrigues D, Gomes L, Carrilho F. Short-and long-term mortality after bariatric surgery: a systematic review and meta-analysis. Diabetes Obes Metab. 2017;19(9):1223–32.

0. 544.  Ozsoy Z, Demir E. Which bariatric procedure is the most popular in the world? A bibliometric comparison. Obes Surg. 2018;28(8):2339–52.

0. 545.  Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S89–96.

0. 546.  Garrow JS. Treatment of obesity. Lancet. 1992;340(8816):409–13.

0. 547.  English WJ, Demaria EJ, Brethauer SA, Mattar SG, Rosenthal RJ, Morton JM. American Society for Metabolic and Bariatric Surgery estimation of metabolic and bariatric procedures performed in the United States in 2016. Surg Obes Relat Dis. 2018;14(3):259–63.

0. 548.  Beaulac J, Sandre D. Critical review of bariatric surgery, medically supervised diets, and behavioural interventions for weight management in adults. Perspect Public Health. 2017;137(3):162–72.

0. 549.  Golzarand M, Toolabi K, Farid R. The bariatric surgery and weight losing: a meta-analysis in the long-and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults. Surg Endosc. 2017;31(11):4331–45.

0. 550.  Panagiotou OA, Markozannes G, Adam GP, et al. Comparative effectiveness and safety of bariatric procedures in Medicare-eligible patients: a systematic review. JAMA Surg. 2018;153(11):e183326.

0. 551.  De Ville K. Bariatric surgery, ethical obligation, and the life cycle of medical innovation. Am J Bioeth. 2010;10(12):22–4.

0. 552.  Dixon JB, Logue J, Komesaroff PA. Promises and ethical pitfalls of surgical innovation: the case of bariatric surgery. Obes Surg. 2013;23(10):1698–702.

0. 553.  English WJ, Demaria EJ, Brethauer SA, Mattar SG, Rosenthal RJ, Morton JM. American Society for Metabolic and Bariatric Surgery estimation of metabolic and bariatric procedures performed in the United States in 2016. Surg Obes Relat Dis. 2018;14(3):259–63.

0. 554.  Pinto-Bastos A, Conceição EM, Machado PPP. Reoperative bariatric surgery: a systematic review of the reasons for surgery, medical and weight loss outcomes, relevant behavioral factors. Obes Surg. 2017;27(10):2707–15.

0. 555.  Bray GA, Frühbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet. 2016;387(10031):1947–56.

0. 556.  Shehab H. Enteral stents in the management of post-bariatric surgery leaks. Surg Obes Relat Dis. 2018;14(3):393–403.

0. 557.  Pinto-Bastos A, Conceição EM, Machado PPP. Reoperative bariatric surgery: a systematic review of the reasons for surgery, medical and weight loss outcomes, relevant behavioral factors. Obes Surg. 2017;27(10):2707–15.

0. 558.  Birkmeyer JD, Finks JF, O’Reilly A, et al. Surgical skill and complication rates after bariatric surgery. N Engl J Med. 2013;369(15):1434–42.

0. 559.  Birkmeyer JD, Finks JF, O’Reilly A, et al. Surgical skill and complication rates after bariatric surgery. N Engl J Med. 2013;369(15):1434–42.

0. 560.  Doumouras AG, Saleh F, Anvari S, Gmora S, Anvari M, Hong D. Mastery in bariatric surgery: the long-term surgeon learning curve of Roux-en-Y gastric bypass. Ann Surg. 2018;267(3):489–94.

0. 561.  Azagury D, Morton JM. Bariatric surgery outcomes in US accredited vs non-accredited centers: a systematic review. J Am Coll Surg. 2016;223(3):469–77.

0. 562.  Bray GA, Frühbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet. 2016;387(10031):1947–56.

0. 563.  Trilk JL, Kennedy AB. Using lifestyle medicine in U.S. health care to treat obesity: too many bariatric surgeries? Curr Sports Med Rep. 2015;14(2):96–9.

0. 564.  Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S89–96.

0. 565.  Rapoport Y, Lavin PJ. Nutritional optic neuropathy caused by copper deficiency after bariatric surgery. J Neuroophthalmol. 2016;36(2):178–81.

0. 566.  Oudman E, Wijnia JW, van Dam M, Biter LU, Postma A. Preventing Wernicke encephalopathy after bariatric surgery. Obes Surg. 2018;28(7):2060–8.

0. 567.  Bohan PK, Yonge J, Connelly C, Watson JJ, Friedman E, Fielding G. Wernicke encephalopathy after restrictive bariatric surgery. Am Surg. 2016;82(4):E73–5.

0. 568.  Sherf Dagan S, Goldenshluger A, Globus I, et al. Nutritional recommendations for adult bariatric surgery patients: clinical practice. Adv Nutr. 2017;8(2):382–94.

0. 569.  Banerjee A, Ding Y, Mikami DJ, Needleman BJ. The role of dumping syndrome in weight loss after gastric bypass surgery. Surg Endosc. 2013;27(5):1573–8.

0. 570.  Hofmann B. Parachutes for diabetes: bariatric surgery beyond evidence? Diabetes Res Clin Pract. 2012;98(3):406–7.

0. 571.  Amouyal C, Andreelli F. What is the evidence for metabolic surgery for type 2 diabetes? A critical perspective. Diabetes Metab. 2017;43(1):9–17.

0. 572.  Taylor R. Calorie restriction and reversal of type 2 diabetes. Expert Rev Endocrinol Metab. 2016;11(6):521–8.

0. 573.  Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.

0. 574.  Pop LM, Mari A, Zhao TJ, et al. Roux-en-Y gastric bypass compared with equivalent diet restriction: mechanistic insights into diabetes remission. Diabetes Obes Metab. 2018;20(7):1710–21.

0. 575.  Taylor R. Calorie restriction and reversal of type 2 diabetes. Expert Rev Endocrinol Metab. 2016;11(6):521–8.

0. 576.  Hall TC, Pellen MG, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20(9):1245–50.

0. 577.  Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J. Leptin reverses weight loss–induced changes in regional neural activity responses to visual food stimuli. J Clin Invest. 2008;118(7):2583–91.

0. 578.  Korner J, Conroy R, Febres G, et al. Randomized double-blind placebo-controlled study of leptin administration after gastric bypass. Obesity (Silver Spring). 2013;21(5):951–6.

0. 579.  Lips MA, van Klinken JB, Pijl H, et al. Weight loss induced by very low calorie diet is associated with a more beneficial systemic inflammatory profile than by Roux-en-Y gastric bypass. Metab Clin Exp. 2016;65(11):1614–20.

0. 580.  Young L, Nor Hanipah Z, Brethauer SA, Schauer PR, Aminian A. Long-term impact of bariatric surgery in diabetic nephropathy. Surg Endosc. 2019;33(5):1654–60.

0. 581.  Cheung D, Switzer NJ, Ehmann D, Rudnisky C, Shi X, Karmali S. The impact of bariatric surgery on diabetic retinopathy: a systematic review and meta-analysis. Obes Surg. 2015;25(9):1604–9.

0. 582.  Chen Y, Laybourne JP, Sandinha MT, et al. Does bariatric surgery prevent progression of diabetic retinopathy? Eye (Lond). 2017;31(8):1131–9.

0. 583.  Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54.

0. 584.  Kempner W. Treatment of heart and kidney disease and of hypertensive and arteriosclerotic vascular disease with the rice diet. Ann Intern Med. 1949;31(5):821–56, illust.

0. 585.  Kempner W, Peschel RL, Schlayer C. Effect of rice diet on diabetes mellitus associated with vascular disease. Postgrad Med. 1958;24(4):359–71.

0. 586.  Mozetic V, Daou JP, Martimbianco AL, Riera R. What do Cochrane systematic reviews say about diabetic retinopathy? Sao Paulo Med J. 2017;135(1):79–87.

0. 587.  Alasil T, Waheed NK. Pan retinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. Curr Opin Ophthalmol. 2014;25(3):164–70.

0. 588.  Kempner W, Newborg BC, Peschel RL, Skyler JS. Treatment of massive obesity with rice/reduction diet program. An analysis of 106 patients with at least a 45-kg weight loss. Arch Intern Med. 1975;135(12):1575–84.

0. 589.  Kempner W. The Treatment of Retinopathy in Kidney Disease and Hypertensive and Arteriosclerotic Vascular Disease with the Rice Diet. Revista dos Tribunais; 1951.

0. 590.  Katz DL. Perspective: obesity is not a disease. Nature. 2014;508(7496):S57.

0. 591.  Magro DO, Geloneze B, Delfini R, Pareja BC, Callejas F, Pareja JC. Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg. 2008;18(6):648–51.

0. 592.  Shukla AP, He D, Saunders KH, Andrew C, Aronne LJ. Current concepts in management of weight regain following bariatric surgery. Expert Rev Endocrinol Metab. 2018;13(2):67–76.

0. 593.  Ghaferi AA, Varban OA. Setting appropriate expectations after bariatric surgery: evaluating weight regain and clinical outcomes. JAMA. 2018;320(15):1543–4.

0. 594.  Pizato N, Botelho PB, Gonçalves VSS, Dutra ES, de Carvalho KMB. Effect of grazing behavior on weight regain post-bariatric surgery: a systematic review. Nutrients. 2017;9(12).

0. 595.  Kruseman M, Leimgruber A, Zumbach F, Golay A. Dietary, weight, and psychological changes among patients with obesity, 8 years after gastric bypass. J Am Diet Assoc. 2010;110(4):527–34.

0. 596.  van Geelen SM, Bolt IL, van der Baan-Slootweg OH, van Summeren MJ. The controversy over pediatric bariatric surgery: an explorative study on attitudes and normative beliefs of specialists, parents, and adolescents with obesity. J Bioeth Inq. 2013;10(2):227–37.

0. 597.  Groven KS, Braithwaite J. Happily-ever-after: personal narratives in weight-loss surgery advertising. Health Care Women Int. 2016;37(11):1221–38.

0. 598.  Rouleau CR, Rash JA, Mothersill KJ. Ethical issues in the psychosocial assessment of bariatric surgery candidates. J Health Psychol. 2016;21(7):1457–71.

0. 599.  Lin HC, Tsao LI. Living with my small stomach: the experiences of post-bariatric surgery patients within 1 year after discharge. J Clin Nurs. 2018;27(23–24):4279–89.

0. 600.  Velapati SR, Shah M, Kuchkuntla AR, et al. Weight regain after bariatric surgery: prevalence, etiology, and treatment. Curr Nutr Rep. 2018;7(4):329–34.

0. 601.  Lu CW, Chang YK, Lee YH, et al. Increased risk for major depressive disorder in severely obese patients after bariatric surgery—a 12-year nationwide cohort study. Ann Med. 2018;50(7):605–12.

0. 602.  Castaneda D, Popov VB, Wander P, Thompson CC. Risk of suicide and self-harm is increased after bariatric surgery—a systematic review and meta-analysis. Obes Surg. 2019;29(1):322–33.

0. 603.  Sarwer DB, Polonsky HM. The psychosocial burden of obesity. Endocrinol Metab Clin North Am. 2016;45(3):677–88.

0. 604.  Neovius M, Bruze G, Jacobson P, et al. Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies. Lancet Diabetes Endocrinol. 2018;6(3):197–207.

0. 605.  Castaneda D, Popov VB, Wander P, Thompson CC. Risk of suicide and self-harm is increased after bariatric surgery—a systematic review and meta-analysis. Obes Surg. 2019;29(1):322–33.

0. 606.  Castaneda D, Popov VB, Wander P, Thompson CC. Risk of suicide and self-harm is increased after bariatric surgery—a systematic review and meta-analysis. Obes Surg. 2019;29(1):322–33.

0. 607.  Castaneda D, Popov VB, Wander P, Thompson CC. Risk of suicide and self-harm is increased after bariatric surgery—a systematic review and meta-analysis. Obes Surg. 2019;29(1):322–33.

0. 608.  Castaneda D, Popov VB, Wander P, Thompson CC. Risk of suicide and self-harm is increased after bariatric surgery—a systematic review and meta-analysis. Obes Surg. 2019;29(1):322–33.

0. 609.  Courcoulas A. Who, why, and how? Suicide and harmful behaviors after bariatric surgery. Ann Surg. 2017;265(2):253–4.

0. 610.  Sarwer DB, Polonsky HM. The psychosocial burden of obesity. Endocrinol Metab Clin North Am. 2016;45(3):677–88.

0. 611.  Steffen KJ, Engel SG, Pollert GA, Li C, Mitchell JE. Blood alcohol concentrations rise rapidly and dramatically after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9(3):470–3.

0. 612.  King WC, Chen JY, Mitchell JE, et al. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA. 2012;307(23):2516–25.

0. 613.  Canetti L, Bachar E, Bonne O. Deterioration of mental health in bariatric surgery after 10 years despite successful weight loss. Eur J Clin Nutr. 2016;70(1):17–22.

0. 614.  Trainer S, Benjamin T. Elective surgery to save my life: rethinking the “choice” in bariatric surgery. J Adv Nurs. 2017;73(4):894–904.

0. 615.  Trainer S, Brewis A, Wutich A. Not “taking the easy way out”: reframing bariatric surgery from low-effort weight loss to hard work. Anthropol Med. 2017;24(1):96–110.

0. 616.  Mattingly B, Stambush M, Hill A. Shedding the pounds but not the stigma: negative attributions as a function of a target’s method of weight loss. J Appl Biobehav Res. 2010;14(3):128–44.

0. 617.  Pinkney JH, Johnson AB, Gale EA. The big fat bariatric bandwagon. Diabetologia. 2010;53(9):1815–22.

0. 618.  Katz D. Obesity … be dammed!: what it will take to turn the tide. Harvard Health Policy Rev. 2006;7(2):135–51.

0. 619.  Oliver JE. The politics of pathology: how obesity became an epidemic disease. Perspect Biol Med. 2006;49(4):611–27.

0. 620.  Hofmann B. Bariatric surgery for obese children and adolescents: a review of the moral challenges. BMC Med Ethics. 2013;14:18.

0. 621.  Alqahtani AR, Antonisamy B, Alamri H, Elahmedi M, Zimmerman VA. Laparoscopic sleeve gastrectomy in 108 obese children and adolescents aged 5 to 21 years. Ann Surg. 2012;256(2):266–73.

0. 622.  Sarr MG. The problem of obesity: how are we going to address it? Am J Bioeth. 2010;10(12):12–3.

0. 623.  Ortiz SE, Kawachi I, Boyce AM. The medicalization of obesity, bariatric surgery, and population health. Health (Lond). 2017;21(5):498–518.

0. 624.  van Geelen SM, Bolt IL, van der Baan-Slootweg OH, van Summeren MJ. The controversy over pediatric bariatric surgery: an explorative study on attitudes and normative beliefs of specialists, parents, and adolescents with obesity. J Bioeth Inq. 2013;10(2):227–37.

0. 625.  Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289(2):187–93.

0. 626.  Cardoso L, Rodrigues D, Gomes L, Carrilho F. Short-and long-term mortality after bariatric surgery: a systematic review and meta-analysis. Diabetes Obes Metab. 2017;19(9):1223–32.

0. 627.  Trainer S, Benjamin T. Elective surgery to save my life: rethinking the “choice” in bariatric surgery. J Adv Nurs. 2017;73(4):894–904.

0. 628.  Vittal H, Raju GS. Endoscopic bubble: can it bust the obesity bubble? Gastroenterology. 2005;129(3):1130–2.

0. 629.  Ross S, Robert M, Harvey MA, et al. Ethical issues associated with the introduction of new surgical devices, or just because we can, doesn’t mean we should. J Obstet Gynaecol Can. 2008;30(6):508–13.

0. 630.  Twardzik M, Wiewiora M, Glück M, Piecuch J. Mechanical intestinal obstruction caused by displacement of a stomach balloon—case report. Wideochir Inne Tech Maloinwazyjne. 2018;13(2):278–81.

0. 631.  Lindor KD, Hughes RW, Ilstrup DM, Jensen MD. Intragastric balloons in comparison with standard therapy for obesity—a randomized, double-blind trial. Mayo Clin Proc. 1987;62(11):992–6.

0. 632.  Benjamin SB, Maher KA, Cattau EL, et al. Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity. Gastroenterology. 1988;95(3):581–8.

0. 633.  Tate CM, Geliebter A. Intragastric balloon treatment for obesity: review of recent studies. Adv Ther. 2017;34(8):1859–75.

0. 634.  English WJ, Demaria EJ, Brethauer SA, Mattar SG, Rosenthal RJ, Morton JM. American Society for Metabolic and Bariatric Surgery estimation of metabolic and bariatric procedures performed in the United States in 2016. Surg Obes Relat Dis. 2018;14(3):259–63.

0. 635.  Ziai K, Pigazzi A, Smith BR, et al. Association of compensation from the surgical and medical device industry to physicians and self-declared conflict of interest. JAMA Surg. 2018;153(11):997–1002.

0. 636.  Camp MW, Mattingly DA, Gross AE, Nousiainen MT, Alman BA, McKneally MF. Patients’ views on surgeons’ financial conflicts of interest. J Bone Joint Surg Am. 2013;95(2):e9(1–8).

0. 637.  Ziai K, Pigazzi A, Smith BR, et al. Association of compensation from the surgical and medical device industry to physicians and self-declared conflict of interest. JAMA Surg. 2018;153(11):997–1002.

0. 638.  United States Food and Drug Administration. Update: potential risks with liquid-filled intragastric balloons—letter to health care providers. FDA.gov. Published August 10, 2017. Available at: https://www.fda.gov/medicaldevices/safety/letterstohealthcareproviders/ucm570707.htm. Accessed March 22, 2019.

0. 639.  Ashrafian H, Monnich M, Braby TS, Smellie J, Bonanomi G, Efthimiou E. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series. Surg Obes Relat Dis. 2018;14(11):1691–9.

0. 640.  Trang J, Lee SS, Miller A, et al. Incidence of nausea and vomiting after intragastric balloon placement in bariatric patients—a systematic review and meta-analysis. Int J Surg. 2018;57:22–9.

0. 641.  Vellante P, Carnevale A, D’Ovidio C. An autopsy case of misdiagnosed Wernicke’s Syndrome after intragastric balloon therapy. Case Rep Gastrointest Med. 2018;2018:1510850.

0. 642.  Saunders KH, Igel LI, Saumoy M, Sharaiha RZ, Aronne LJ. Devices and endoscopic bariatric therapies for obesity. Curr Obes Rep. 2018;7(2):162–71.

0. 643.  United States Food and Drug Administration. The FDA alerts health care providers about potential risks with liquid-filled intragastric balloons. FDA.gov. Published February 9, 2017. Available at: https://www.fda.gov/MedicalDevices/Safety/LetterstoHealthCareProviders/ucm540655.htm. Accessed March 22, 2019.

0. 644.  de Quadros LG, Dos Passos Galvão Neto M, Grecco E, et al. Intragastric balloon hyperinsufflation as a cause of acute obstructive abdomen. ACG Case Rep J. 2018;5:e69.

0. 645.  Landon J, DiGregorio V. The phenomenon of the spontaneously autoinflating breast implant. Northeastern Society of Plastic Surgeons. 2014. Available at: http://meeting.nesps.org/abstracts/2014/54.cgi. Accessed March 21, 2019.

0. 646.  Landon J, DiGregorio V. The phenomenon of the spontaneously autoinflating breast implant. Northeastern Society of Plastic Surgeons. 2014. Available at: http://meeting.nesps.org/abstracts/2014/54.cgi. Accessed March 21, 2019.

0. 647.  Robinson OG, Benos DJ, Mazzochi C. Spontaneous autoinflation of saline mammary implants: further studies. Aesthet Surg J. 2005;25(6):582–6.

0. 648.  Hogan RB, Johnston JH, Long BW, et al. A double-blind, randomized, sham-controlled trial of the gastric bubble for obesity. Gastrointest Endosc. 1989;35(5):381–5.

0. 649.  Ali MR, Moustarah F, Kim JJ. American Society for Metabolic and Bariatric Surgery position statement on intragastric balloon therapy endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons. Surg Obes Relat Dis. 2016;12(3):462–7.

0. 650.  Maffulli N. We are operating too much. J Orthop Traumatol. 2017;18(4):289–92.

0. 651.  Moseley JB, O’Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347(2):81–8.

0. 652.  Sihvonen R, Paavola M, Malmivaara A, et al. Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. N Engl J Med. 2013;369(26):2515–24.

0. 653.  Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391(10115):31–40.

0. 654.  McCormack RG, Hutchinson MR. Rocking the shoulder surgeon’s world. Br J Sports Med. 2017;51(24):1727.

0. 655.  Hogan RB, Johnston JH, Long BW, et al. A double-blind, randomized, sham-controlled trial of the gastric bubble for obesity. Gastrointest Endosc. 1989;35(5):381–5.

0. 656.  Martinez-Brocca MA, Belda O, Parejo J, et al. Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity. Obes Surg. 2007;17(5):649–57.

0. 657.  Genco A, Cipriano M, Bacci V, et al. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond). 2006;30(1):129–33.

0. 658.  Dumonceau JM, François E, Hittelet A, Mehdi AI, Barea M, Deviere J. Single vs repeated treatment with the intragastric balloon: a 5-year weight loss study. Obes Surg. 2010;20(6):692–7.

0. 659.  Martinez-Brocca MA, Belda O, Parejo J, et al. Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity. Obes Surg. 2007;17(5):649–57.

0. 660.  Thorlund JB. Deconstructing a popular myth: why knee arthroscopy is no better than placebo surgery for degenerative meniscal tears. Br J Sports Med. 2017;51(22):1630–1.

0. 661.  Rongen JJ, Rovers MM, van Tienen TG, Buma P, Hannink G. Increased risk for knee replacement surgery after arthroscopic surgery for degenerative meniscal tears: a multi-center longitudinal observational study using data from the osteoarthritis initiative. Osteoarthr Cartil. 2017;25(1):23–9.

0. 662.  Orchard J, Moen MH. Has reimbursement for knee osteoarthritis treatments now reached “postfact” status? Br J Sports Med. 2017;51(21):1510–1.

0. 663.  Xia Y, Kelton CM, Guo JJ, Bian B, Heaton PC. Treatment of obesity: pharmacotherapy trends in the United States from 1999 to 2010. Obesity (Silver Spring). 2015;23(8):1721–8.

0. 664.  Halpern B, Halpern A. Why are anti-obesity drugs stigmatized? Expert Opin Drug Saf. 2015;14(2):185–9.

0. 665.  McGee S. Getting unstuck: rubber bands and public health. Am J Bioeth. 2010;10(12):1–2.

0. 666.  Wharton S, Serodio KJ. Next generation of weight management medications: implications for diabetes and CVD risk. Curr Cardiol Rep. 2015;17(5):35.

0. 667.  Colman E. Dinitrophenol and obesity: an early twentieth-century regulatory dilemma. Regul Toxicol Pharmacol. 2007;48(2):115–7.

0. 668.  Rodin FH. Cataracts following the use of dinitrophenol: a summary of thirty-two cases. Cal West Med. 1936;44(4):276–9.

0. 669.  Center for Drug Evaluation and Research 2002. Defendant pleads guilty in internet drug case. United States Food and Drug Administration. Available at: https://www.fda.gov/iceci/enforcementactions/enforcementstory/enforcementstoryarchive/ucm103554.htm. Accessed March 22, 2019.

0. 670.  Miranda EJ, McIntyre IM, Parker DR, Gary RD, Logan BK. Two deaths attributed to the use of 2,4-dinitrophenol. J Anal Toxicol. 2006;30(3):219–22.

0. 671.  Ahrnsbrak R, Bose J, Hedden SL, Lipari RN, Park-Lee E. Key substance use and mental health indicators in the United States: results from the 2016 national survey on drug use and health. Substance Abuse and Mental Health Services Administration. Published September 2017. Available at: https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUH-FFR1-2016.pdf. Accessed March 22, 2019.

0. 672.  Rasmussen N. America’s first amphetamine epidemic 1929–1971: a quantitative and qualitative retrospective with implications for the present. Am J Public Health. 2008;98(6):974–85.

0. 673.  Rasmussen N. America’s first amphetamine epidemic 1929–1971: a quantitative and qualitative retrospective with implications for the present. Am J Public Health. 2008;98(6):974–85.

0. 674.  Graham J. Amphetamine politics on Capitol Hill. Society. 1972;9(3):14–22.

0. 675.  McGee M, Whitehead N, Martin J, Collins N. Drug-associated pulmonary arterial hypertension. Clin Toxicol (Phila). 2018;56(9):801–9.

0. 676.  Kassirer JP, Angell M. Losing weight—an ill-fated New Year’s resolution. N Engl J Med. 1998;338(1):52–4.

0. 677.  Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337(9):581–8.

0. 678.  James WP, Caterson ID, Coutinho W, et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363(10):905–17.

0. 679.  Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet. 2007;370(9600):1706–13.

0. 680.  Lagerros YT, Rössner S. Obesity management: what brings success? Therap Adv Gastroenterol. 2013;6(1):77–88.

0. 681.  Haslam D. Weight management in obesity—past and present. Int J Clin Pract. 2016;70(3):206–17.

0. 682.  Chawla A, Carls G, Deng E, Tuttle E. The expected net present value of developing weight management drugs in the context of drug safety litigation. Pharmacoeconomics. 2015;33(7):749–63.

0. 683.  Diet, drugs, devices, and surgery for weight management. Med Lett Drugs Ther. 2018;60(1548):91–8.

0. 684.  Woloshin S, Schwartz LM. The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings? JAMA Intern Med. 2014;174(4):615–9.

0. 685.  Nuffer W, Trujillo JM, Megyeri J. A comparison of new pharmacological agents for the treatment of obesity. Ann Pharmacother. 2016;50(5):376–88.

0. 686.  Rodríguez JE, Campbell KM. Past, present, and future of pharmacologic therapy in obesity. Prim Care. 2016;43(1):61–7,viii.

0. 687.  Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11–22.

0. 688.  Igel LI, Kumar RB, Saunders KH, Aronne LJ. Practical use of pharmacotherapy for obesity. Gastroenterology. 2017;152(7):1765–79.

0. 689.  Igel LI, Kumar RB, Saunders KH, Aronne LJ. Practical use of pharmacotherapy for obesity. Gastroenterology. 2017;152(7):1765–79.

0. 690.  Shepherd RW. No evidence for benefit of medication for obesity. Can Fam Physician. 2017;63(4):276.

0. 691.  Hollander PA, Elbein SC, Hirsch IB, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care. 1998;21(8):1288–94.

0. 692.  Schroll JB, Penninga EI, Gøtzsche PC. Assessment of adverse events in protocols, clinical study reports, and published papers of trials of orlistat: a document analysis. PLoS Med. 2016;13(8):e1002101.

0. 693.  Bourns L, Shiau J. Rebuttal: should family physicians prescribe medication for obesity? YES. Can Fam Physician. 2017;63(2):e82.

0. 694.  Haddock CK, Poston WS, Dill PL, Foreyt JP, Ericsson M. Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes Relat Metab Disord. 2002;26(2):262–73.

0. 695.  Rodríguez JE, Campbell KM. Past, present, and future of pharmacologic therapy in obesity. Prim Care. 2016;43(1):61–7,viii.

0. 696.  Hemo B, Endevelt R, Porath A, Stampfer MJ, Shai I. Adherence to weight loss medications; post-marketing study from HMO pharmacy data of one million individuals. Diabetes Res Clin Pract. 2011;94(2):269–75.

0. 697.  Glauser TA, Roepke N, Stevenin B, Dubois AM, Ahn SM. Physician knowledge about and perceptions of obesity management. Obes Res Clin Pract. 2015;9(6):573–83.

0. 698.  Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62.

0. 699.  Yeh JS, Kushner RF, Schiff GD. Obesity and management of weight loss. N Engl J Med. 2016;375(12):1187–9.

0. 700.  Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62.

0. 701.  Brauer P, Connor Gorber S, Shaw E, et al. Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care. CMAJ. 2015;187(3):184–95.

0. 702.  Pillitteri JL, Shiffman S, Rohay JM, Harkins AM, Burton SL, Wadden TA. Use of dietary supplements for weight loss in the United States: results of a national survey. Obesity (Silver Spring). 2008;16(4):790–6.

0. 703.  Austin SB, Yu K, Liu SH, Dong F, Tefft N. Household expenditures on dietary supplements sold for weight loss, muscle building, and sexual function: disproportionate burden by gender and income. Prev Med Rep. 2017;6:236–41.

0. 704.  Pillitteri JL, Shiffman S, Rohay JM, Harkins AM, Burton SL, Wadden TA. Use of dietary supplements for weight loss in the United States: results of a national survey. Obesity (Silver Spring). 2008;16(4):790–6.

0. 705.  United States Government Accountability Office. Dietary supplements: FDA should take further actions to improve oversight and consumer understanding. GAO.gov. Published January 29, 2009. Available at: https://www.gao.gov/products/GAO-09-250. Accessed March 22, 2019.

0. 706.  Marcus DM. Dietary supplements: what’s in a name? What’s in the bottle? Drug Test Anal. 2016;8(3–4):410–2.

0. 707.  Starfield B. Is US health really the best in the world? JAMA. 2000;284(4):483–5.

0. 708.  Center for Drug Evaluation and Research. Drug approval process. United States Food and Drug Administration. Available at: https://www.fda.gov/downloads/drugs/resourcesforyou/consumers/ucm284393.pdf. Accessed March 22, 2019.

0. 709.  Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord. 2001;25(3):316–24.

0. 710.  Statement of Marcia Crosse. Dietary supplements containing ephedra: health risks and FDA’s oversight. United States Government Accountability Office. Published July 23, 2003. Available at: https://www.gao.gov/products/GAO-03-1042T. Accessed March 22, 2019.

0. 711.  Long J. FDA GMP inspectors cite 70% of dietary supplement firms. Natural Products INSIDER. Published May 20, 2013. Available at: https://www.naturalproductsinsider.com/fda-gmp-inspectors-cite-70-dietary-supplement-firms. Accessed March 22, 2019.

0. 712.  Newmaster SG, Grguric M, Shanmughanandhan D, Ramalingam S, Ragupathy S. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med. 2013;11:222.

0. 713.  Vilanova-Sanchez A, Gasior AC, Toocheck N, et al. Are Senna based laxatives safe when used as long term treatment for constipation in children? J Pediatr Surg. 2018;53(4):722–7.

0. 714.  Newmaster SG, Grguric M, Shanmughanandhan D, Ramalingam S, Ragupathy S. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med. 2013;11:222.

0. 715.  O’Connor A. New York attorney general targets supplements at major retailers. New York Times. Published February 3, 2015. Available at: https://well.blogs.nytimes.com/2015/02/03/new-york-attorney-general-targets-supplements-at-major-retailers. Accessed March 22, 2019.

0. 716.  Marcus DM. Dietary supplements: what’s in a name? What’s in the bottle? Drug Test Anal. 2016;8(3–4):410–2.

0. 717.  Hachem R, Assemat G, Martins N, et al. Proton NMR for detection, identification and quantification of adulterants in 160 herbal food supplements marketed for weight loss. J Pharm Biomed Anal. 2016;124:34–47.

0. 718.  Moreira AP, Motta MJ, Dal Molin TR, Viana C, de Carvalho LM. Determination of diuretics and laxatives as adulterants in herbal formulations for weight loss. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2013;30(7):1230–7.

0. 719.  Eichner S, Maguire M, Shea LA, Fete MG. Banned and discouraged-use ingredients found in weight loss supplements. J Am Pharm Assoc (2003). 2016;56(5):538–43.

0. 720.  Mathews NM. Prohibited contaminants in dietary supplements. Sports Health. 2018;10(1):19–30.

0. 721.  Chen SP, Tang MH, Ng SW, Poon WT, Chan AY, Mak TW. Psychosis associated with usage of herbal slimming products adulterated with sibutramine: a case series. Clin Toxicol (Phila). 2010;48(8):832–8.

0. 722.  Ozdemir B, Sahin I, Kapucu H, et al. How safe is the use of herbal weight-loss products sold over the internet? Hum Exp Toxicol. 2013;32(1):101–6.

0. 723.  Cohen PA, Maller G, Desouza R, Neal-Kababick J. Presence of banned drugs in dietary supplements following FDA recalls. JAMA. 2014;312(16):1691–3.

0. 724.  Marcus DM. Dietary supplements: what’s in a name? What’s in the bottle? Drug Test Anal. 2016;8(3–4):410–2.

0. 725.  Petróczi A, Ocampo JA, Shah I, et al. Russian roulette with unlicensed fat-burner drug 2,4-dinitrophenol (DNP): evidence from a multidisciplinary study of the internet, bodybuilding supplements and DNP users. Subst Abuse Treat Prev Policy. 2015;10:39.

0. 726.  Slomski A. A trip on “bath salts” is cheaper than meth or cocaine but much more dangerous. JAMA. 2012;308(23):2445–7.

0. 727.  Mathews NM. Prohibited contaminants in dietary supplements. Sports Health. 2018;10(1):19–30.

0. 728.  Archer JR, Dargan PI, Lostia AM, et al. Running an unknown risk: a marathon death associated with the use of 1,3-dimethylamylamine (DMAA). Drug Test Anal. 2015;7(5):433–8.

0. 729.  Young C, Oladipo O, Frasier S, Putko R, Chronister S, Marovich M. Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d. Mil Med. 2012;177(12):1450–4.

0. 730.  Cohen PA, Travis JC, Keizers PHJ, Deuster P, Venhuis BJ. Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA). Clin Toxicol (Phila). 2018;56(6):421–6.

0. 731.  Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003;289(12):1537–45.

0. 732.  Mullin GE. Supplements for weight loss: hype or help for obesity? Part III. Nutr Clin Pract. 2015;30(3):446–9.

0. 733.  Gibson-Moore H. Do slimming supplements work? Nutr Bull. 2010;34(4):300–3.

0. 734.  Onakpoya IJ, Wider B, Pittler MH, Ernst E. Food supplements for body weight reduction: a systematic review of systematic reviews. Obesity (Silver Spring). 2011;19(2):239–44.

0. 735.  Poddar K, Kolge S, Bezman L, Mullin GE, Cheskin LJ. Nutraceutical supplements for weight loss: a systematic review. Nutr Clin Pract. 2011;26(5):539–52.

0. 736.  Chang YY, Chiou WB. The liberating effect of weight loss supplements on dietary control: a field experiment. Nutrition. 2014;30(9):1007–10.

0. 737.  Chiou WB, Wan CS, Wu WH, Lee KT. A randomized experiment to examine unintended consequences of dietary supplement use among daily smokers: taking supplements reduces self-regulation of smoking. Addiction. 2011;106(12):2221–8.

0. 738.  Chiou WB, Yang CC, Wan CS. Ironic effects of dietary supplementation: illusory invulnerability created by taking dietary supplements licenses health-risk behaviors. Psychol Sci. 2011;22(8):1081–6.

0. 739.  Chang YY, Chiou WB. The liberating effect of weight loss supplements on dietary control: a field experiment. Nutrition. 2014;30(9):1007–10.

0. 740.  Chang YY, Chiou WB. Taking weight-loss supplements may elicit liberation from dietary control. A laboratory experiment. Appetite. 2014;72:8–12.

0. 741.  Chiou WB, Yang CC, Wan CS. Ironic effects of dietary supplementation: illusory invulnerability created by taking dietary supplements licenses health-risk behaviors. Psychol Sci. 2011;22(8):1081–6.

0. 742.  World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Published 2013. Available at: https://www.who.int/nmh/events/ncd_action_plan/en. Accessed March 22, 2019.

0. 743.  Roberto CA, Swinburn B, Hawkes C, et al. Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking. Lancet. 2015;385(9985):2400–9.

0. 744.  Neal B. Fat chance for physical activity. Popul Health Metr. 2013;11(1):9.

0. 745.  Roberto CA, Swinburn B, Hawkes C, et al. Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking. Lancet. 2015;385(9985):2400–9.

0. 746.  Murray S. The world’s biggest industry. Forbes. Published November 15, 2007. Available at: https://www.forbes.com/2007/11/11/growth-agriculture-business-forbeslife-food07-cx_sm_1113bigfood.html. Accessed March 22, 2019.

0. 747.  Packaged food market is expected to reach $3.03 trillion, globally, by 2020. Allied Market Research. 2015. Available at: https://www.alliedmarketresearch.com/press-release/packaged-food-market-is-expected-to-reach-3.03-trillion-worldwide-by-2020-allied-market-research.html. Accessed March 22, 2019.

0. 748.  Neal B. Fat chance for physical activity. Popul Health Metr. 2013;11(1):9.

0. 749.  Marlow M. Weight loss nudges: market test or government guess? Mercatus Center at George Mason University. Published September 2014. Available at: https://www.mercatus.org/system/files/Marlow-Weight-Loss-Nudges.pdf. Accessed March 22, 2019.

0. 750.  Marlow M. Weight loss nudges: market test or government guess? Mercatus Center at George Mason University. Published September 2014. Available at: https://www.mercatus.org/system/files/Marlow-Weight-Loss-Nudges.pdf. Accessed March 22, 2019.

0. 751.  Kirkwood K. Lipids, liberty, and the integrity of free actions. Am J Bioeth. 2010;10(3):45–6.

0. 752.  Popkin BM. Agricultural policies, food and public health. EMBO Rep. 2011;12(1):11–8.

0. 753.  Brownell KD, Warner KE. The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? Milbank Q. 2009;87(1):259–94.

0. 754.  Engelhard CL, Garson A, Dorn S. Reducing obesity: policy strategies from the tobacco wars. Methodist Debakey Cardiovasc J. 2009;5(4):46–50.

0. 755.  Jamal A, Phillips E, Gentzke AS, et al. Current cigarette smoking among adults—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(2):53–9.

0. 756.  Mokdad AH, Ballestros K, Echko M, et al. The state of US health, 1990–2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319(14):1444–72.

0. 757.  Lagerros YT, Rössner S. Obesity management: what brings success? Therap Adv Gastroenterol. 2013;6(1):77–88.

0. 758.  Engelhard CL, Garson A, Dorn S. Reducing obesity: policy strategies from the tobacco wars. Methodist Debakey Cardiovasc J. 2009;5(4):46–50.

0. 759.  Biener L, Aseltine RH, Cohen B, Anderka M. Reactions of adult and teenaged smokers to the Massachusetts tobacco tax. Am J Public Health. 1998;88(9):1389–91.

0. 760.  World Health Organization. WHO report on the global tobacco epidemic, 2008. Published 2008. Available at: https://www.who.int/tobacco/mpower/gtcr_download/en. Accessed March 22, 2019.

0. 761.  Smith A. An Inquiry into the Nature and Causes of the Wealth of Nations. Methuen and Co Ltd; 1904.

0. 762.  Engelhard CL, Garson A, Dorn S. Reducing obesity: policy strategies from the tobacco wars. Methodist Debakey Cardiovasc J. 2009;5(4):46–50.

0. 763.  Graff SK, Kappagoda M, Wooten HM, McGowan AK, Ashe M. Policies for healthier communities: historical, legal, and practical elements of the obesity prevention movement. Annu Rev Public Health. 2012;33:307–24.

0. 764.  Engelhard CL, Garson A, Dorn S. Reducing obesity: policy strategies from the tobacco wars. Methodist Debakey Cardiovasc J. 2009;5(4):46–50.

0. 765.  Marshall T. Exploring a fiscal food policy: the case of diet and ischaemic heart disease. BMJ. 2000;320(7230):301–5.

0. 766.  Thow AM, Downs S, Jan S. A systematic review of the effectiveness of food taxes and subsidies to improve diets: understanding the recent evidence. Nutr Rev. 2014;72(9):551–65.

0. 767.  Marshall T. Exploring a fiscal food policy: the case of diet and ischaemic heart disease. BMJ. 2000;320(7230):301–5.

0. 768.  Marshall T. Exploring a fiscal food policy: the case of diet and ischaemic heart disease. BMJ. 2000;320(7230):301–5.

0. 769.  Koh HK. An analysis of the successful 1992 Massachusetts tobacco tax initiative. Tob Control. 1996;5(3):220–5.

0. 770.  Smith KE, Savell E, Gilmore AB. What is known about tobacco industry efforts to influence tobacco tax? A systematic review of empirical studies. Tob Control. 2013;22(2):144–53.

0. 771.  Waterlander WE, Steenhuis IH, de Boer MR, Schuit AJ, Seidell JC. The effects of a 25% discount on fruits and vegetables: results of a randomized trial in a three-dimensional web-based supermarket. Int J Behav Nutr Phys Act. 2012;9:11.

0. 772.  Ananthapavan J, Peterson A, Sacks G. Paying people to lose weight: the effectiveness of financial incentives provided by health insurers for the prevention and management of overweight and obesity—a systematic review. Obes Rev. 2018;19(5):605–13.

0. 773.  An R, Patel D, Segal D, Sturm R. Eating better for less: a national discount program for healthy food purchases in South Africa. Am J Health Behav. 2013;37(1):56–61.

0. 774.  Ananthapavan J, Peterson A, Sacks G. Paying people to lose weight: the effectiveness of financial incentives provided by health insurers for the prevention and management of overweight and obesity—a systematic review. Obes Rev. 2018;19(5):605–13.

0. 775.  Yancy WS, Shaw PA, Wesby L, et al. Financial incentive strategies for maintenance of weight loss: results from an internet-based randomized controlled trial. Nutr Diabetes. 2018;8(1):33.

0. 776.  Cawley J. Does anything work to reduce obesity? (Yes, modestly). J Health Polit Policy Law. 2016;41(3):463–72.

0. 777.  Rahkovsky I, Gregory CA. Food prices and blood cholesterol. Econ Hum Biol. 2013;11(1):95–107.

0. 778.  Cash S, Sunding D, Zilberman D. Fat taxes and thin subsidies: prices, diet, and health outcomes. Acta Agr Scand C. 2005;2(3–4):167–74.

0. 779.  Hanks A, Wansink B, Just D, et al. From Coke to Coors: a field study of a fat tax and its unintended consequences. J Nutr Educ Behav. 2013;45(4):S40. Note: The legitimacy of Brian Wansink’s research has been called into serious question. See, for example, https://www.chronicle.com/article/Spoiled-Science/239529.

0. 780.  Jue JJ, Press MJ, McDonald D, et al. The impact of price discounts and calorie messaging on beverage consumption: a multi-site field study. Prev Med. 2012;55(6):629–33.

0. 781.  Brown AW, Allison DB. Unintended consequences of obesity-targeted health policy. Virtual Mentor. 2013;15(4):339–46.

0. 782.  Richardson MB, Williams MS, Fontaine KR, Allison DB. The development of scientific evidence for health policies for obesity: why and how? Int J Obes (Lond). 2017;41(6):840–8.

0. 783.  Folkvord F, Anschütz DJ, Buijzen M, Valkenburg PM. The effect of playing advergames that promote energy-dense snacks or fruit on actual food intake among children. Am J Clin Nutr. 2013;97(2):239–45.

0. 784.  At a glance. Reducing tobacco use: a report of the Surgeon General—2000. Oncology (Williston Park, NY). 2000;14(12):1671,1675,1764–5.

0. 785.  Bolton L, Cohen J, Bloom P. Does marketing products as remedies create “get out of jail free cards”? J Consum Res. 2006;33(1):71–81.

0. 786.  Bolton L, Cohen J, Bloom P. Does marketing products as remedies create “get out of jail free cards”? J Consum Res. 2006;33(1):71–81.

0. 787.  Burgers triumph over baguettes in French fast food wars. Local. Published March 20, 2018. Available at: https://www.thelocal.fr/20180320/burgers-triumph-against-baguettes-in-french-fast-food-wars. Accessed March 22, 2019.

0. 788.  Hawkes C. Regulating and litigating in the public interest: regulating food marketing to young people worldwide: trends and policy drivers. Am J Public Health. 2007;97(11):1962–73.

0. 789.  Arrêté du 27 février 2007 fixant les conditions relatives aux informations à caractère sanitaire devant accompagner les messages publicitaires ou promotionnels en faveur de certains aliments et boissons. Légifrance. Published February 27, 2007. Available at: https://www.legifrance.gouv.fr/eli/arrete/2007/2/27/SANP0720073A/jo/texte. Accessed March 22, 2019.

0. 790.  Werle C, Cuny C. The boomerang effect of mandatory sanitary messages to prevent obesity. Mark Lett. 2012;23(3):883–91.

0. 791.  Werle C, Cuny C. The boomerang effect of mandatory sanitary messages to prevent obesity. Mark Lett. 2012;23(3):883–91.

0. 792.  Werle C, Cuny C. The boomerang effect of mandatory sanitary messages to prevent obesity. Mark Lett. 2012;23(3):883–91.

0. 793.  Caraher M, Cowburn G. Guest commentary: fat and other taxes, lessons for the implementation of preventive policies. Prev Med. 2015;77:204–6.

0. 794.  Moore M, Yeatman H, Davey R. Which nanny—the state or industry? Wowsers, teetotallers and the fun police in public health advocacy. Public Health. 2015;129(8):1030–7.

0. 795.  Gostin LO. Bloomberg’s health legacy: urban innovator or meddling nanny? Hastings Cent Rep. 2013;43(5):19–25.

0. 796.  Mejia P, Dorfman L, Cheyne A, et al. The origins of personal responsibility rhetoric in news coverage of the tobacco industry. Am J Public Health. 2014;104(6):1048–51.

0. 797.  Gostin LO, Gostin KG. A broader liberty: J.S. Mill, paternalism and the public’s health. Public Health. 2009;123(3):214–21.

0. 798.  Gostin LO, Gostin KG. A broader liberty: J.S. Mill, paternalism and the public’s health. Public Health. 2009;123(3):214–21.

0. 799.  Hoek J. Informed choice and the nanny state: learning from the tobacco industry. Public Health. 2015;129(8):1038–45.

0. 800.  Gostin LO, Gostin KG. A broader liberty: J.S. Mill, paternalism and the public’s health. Public Health. 2009;123(3):214–21.

0. 801.  World Health Organization. WHO Director-General addresses health promotion conference. Published June 10, 2013. Available at: http://www.who.int/dg/speeches/2013/health_promotion_20130610/en. Accessed March 22, 2019.

0. 802.  Brown & Williamson. Smoking and health proposal. 1969. Available at: https://www.industrydocuments.ucsf.edu/tobacco/docs/#id=jryf0138. Accessed March 22, 2019.

0. 803.  Ibrahim JK, Glantz SA. The rise and fall of tobacco control media campaigns, 1967–2006. Am J Public Health. 2007;97(8):1383–96.

0. 804.  Weimholt J. “Bringing a butter knife to a gun fight”? Salience, disclosure, and FDA’s differing approaches to the tobacco use and obesity epidemics. Food Drug Law J. 2015;70(4):501–51,i.

0. 805.  Engelhard CL, Garson A, Dorn S. Reducing obesity: policy strategies from the tobacco wars. Methodist Debakey Cardiovasc J. 2009;5(4):46–50.

0. 806.  Engelhard CL, Garson A, Dorn S. Reducing obesity: policy strategies from the tobacco wars. Methodist Debakey Cardiovasc J. 2009;5(4):46–50.

0. 807.  Watson E. Front-of-pack nutrition labels prompt surprise swing in sales. Food Manufacture. Published May 1, 2006. Available at: https://www.foodmanufacture.co.uk/Article/2006/05/02/Front-of-pack-nutrition-labels-prompt-surprise-swing-in-sales. Accessed March 22, 2019.

0. 808.  Mindell JS, Reynolds L, Cohen DL, McKee M. All in this together: the corporate capture of public health. BMJ. 2012;345:e8082.

0. 809.  Bleich SN, Wolfson JA, Jarlenski MP, Block JP. Restaurants with calories displayed on menus had lower calorie counts compared to restaurants without such labels. Health Aff (Millwood). 2015;34(11):1877–84.

0. 810.  Dumanovsky T, Huang CY, Nonas CA, Matte TD, Bassett MT, Silver LD. Changes in energy content of lunchtime purchases from fast food restaurants after introduction of calorie labelling: cross sectional customer surveys. BMJ. 2011;343:d4464.

0. 811.  Berry C, Burton S, Howlett E. The effects of voluntary versus mandatory menu calorie labeling on consumers’ retailer-related responses. J Retailing. 2017;94(1):73–88.

0. 812.  Strom S. McDonald’s to start posting calorie counts. New York Times. Published September 12, 2012. Available at: https://www.nytimes.com/2012/09/13/business/mcdonalds-to-start-posting-calorie-counts.html. Accessed March 22, 2019.

0. 813.  Wilcox K, Vallen B, Block L, Fitzsimons G. Vicarious goal fulfillment: when the mere presence of a healthy option leads to an ironically indulgent decision. J Consum Res. 2009;36(3):380–93.

0. 814.  Wilcox K, Vallen B, Block L, Fitzsimons G. Vicarious goal fulfillment: when the mere presence of a healthy option leads to an ironically indulgent decision. J Consum Res. 2009;36(3):380–93.

0. 815.  Chernev A. The dieter’s paradox. J Consum Psychol. 2011;21(2):178–83.

0. 816.  Chandon P, Wansink B. The biasing health halos of fast-food restaurant health claims: lower calorie estimates and higher side-dish consumption intentions. J Consum Res. 2007;34(3):301–14. Note: The legitimacy of Brian Wansink’s research has been called into serious question. See, for example, https://www.chronicle.com/article/Spoiled-Science/239529.

0. 817.  Werle C, Cuny C. The boomerang effect of mandatory sanitary messages to prevent obesity. Mark Lett. 2012;23(3):883–91.

0. 818.  Wilcox K, Vallen B, Block L, Fitzsimons G. Vicarious goal fulfillment: when the mere presence of a healthy option leads to an ironically indulgent decision. J Consum Res. 2009;36(3):380–93.

0. 819.  Lagerros YT, Rössner S. Obesity management: what brings success? Therap Adv Gastroenterol. 2013;6(1):77–88.

0. 820.  Chopra M, Darnton-Hill I. Tobacco and obesity epidemics: not so different after all? BMJ. 2004;328(7455):1558–60.

0. 821.  Institute of Medicine. Food marketing to children and youth: threat or opportunity? National Academies Press. 2006. Available at: https://www.nap.edu/catalog/11514/food-marketing-to-children-and-youth-threat-or-opportunity. Accessed on March 22, 2019.

0. 822.  Lyons R. Ban on sugary-cereal TV ads urged. New York Times. Published March 6, 1973. Available at: https://www.nytimes.com/1973/03/06/archives/ban-on-sugarycereal-tv-ads-urged-sugarcoated-nothings-115-pounds-of.html. Accessed March 22, 2019.

0. 823.  Congress of the United States Hearings Before the Select Committee on Nutrition and Human Needs of the United States Senate, Ninety-Second Congress, Second Session. Nutrition Education—1972. Part 1—Overview; Consultants’ Recommendations. Washington, D.C., December 6, 1972. Washington, D.C.; 1972:1–191.

0. 824.  Congress of the United States Hearings Before the Select Committee on Nutrition and Human Needs of the United States Senate, Ninety-Third Congress, First Session. Nutrition Education—1973. Parts 3, 4, and 5—TV Advertising of Food to Children. Washington, D.C., March 5, 6, and 12, 1973. Washington, D.C.; 1973:1–546.

0. 825.  Congress of the United States Hearings Before the Select Committee on Nutrition and Human Needs of the United States Senate, Ninety-Third Congress, First Session. Nutrition Education—1973. Parts 3, 4, and 5—TV Advertising of Food to Children. Washington, D.C., March 5, 6, and 12, 1973. Washington, D.C.; 1973:1–546.

0. 826.  Congress of the United States Hearings Before the Select Committee on Nutrition and Human Needs of the United States Senate, Ninety-Third Congress, First Session. Nutrition Education—1973. Parts 3, 4, and 5—TV Advertising of Food to Children. Washington, D.C., March 5, 6, and 12, 1973. Washington, D.C.; 1973:1–546.

0. 827.  Children’s Food & Beverage Advertising Initiative. White paper on CFBAI’s uniform nutrition criteria. Council of Better Business Bureaus. Published July 2011. Available at: https://www.bbb.org/us/storage/0/Shared%20Documents/White%20Paper%20on%20CFBAI%20Uniform%20Nutrition%20Criteria%20July%202011.pdf. Accessed March 22, 2019.

0. 828.  Harris JL, LoDolce M, Dembek C, Schwartz MB. Sweet promises: candy advertising to children and implications for industry self-regulation. Appetite. 2015;95:585–92.

0. 829.  LoDolce ME, Harris JL, Schwartz MB. Sugar as part of a balanced breakfast? What cereal advertisements teach children about healthy eating. J Health Commun. 2013;18(11):1293–309.

0. 830.  Dietz WH. New strategies to improve food marketing to children. Health Aff (Millwood). 2013;32(9):1652–8.

0. 831.  Pestano P, Yeshua E, Houlihan J. Sugar in children’s cereals: popular brands pack more sugar than snack cakes and cookies. Environmental Working Group. Published December 2011. Available at: https://www.foodpolitics.com/wp-content/uploads/CEREALSewg_press_cereal_report.pdf. Accessed March 22, 2019.

0. 832.  Harris JL, Schwartz MB, Brownell KD, et al. Cereal FACTS 2012: limited progress in the nutrition quality and marketing of children’s cereals. Rudd Center for Food Policy & Obesity. Published June 2012. Available at: http://www.cerealfacts.org/media/cereal_facts_report_2012_7.12.pdf. Accessed March 22, 2019.

0. 833.  Westen T. Government regulation of food marketing to children: the Federal Trade Commission and the Kid-Vid controversy. Loyola Los Angel Law Rev. Published May 1, 2006. Available at: https://digitalcommons.lmu.edu/llr/vol39/iss1/4. Accessed March 22, 2019.

0. 834.  Dietz WH. New strategies to improve food marketing to children. Health Aff (Millwood). 2013;32(9):1652–8.

0. 835.  Federal Trade Commission. Interagency Working Group seeks input on proposed voluntary principles for marketing food to children. FTC.gov. Published April 28, 2011. Available at: https://www.ftc.gov/news-events/press-releases/2011/04/interagency-working-group-seeks-input-proposed-voluntary. Accessed March 22, 2019.

0. 836.  Federal Trade Commission. Interagency Working Group on food marketed to children. Preliminary proposed nutrition principles to guide industry self-regulatory efforts. Available at: https://www.ftc.gov/sites/default/files/documents/public_events/food-marketed-children-forum-interagency-working-group-proposal/110428foodmarketproposedguide.pdf. Accessed March 22, 2019.

0. 837.  Harris JL, Schwartz MB, Brownell KD, et al. Cereal FACTS 2012: limited progress in the nutrition quality and marketing of children’s cereals. Rudd Center for Food Policy & Obesity. Published June 2012. Available at: http://www.cerealfacts.org/media/cereal_facts_report_2012_7.12.pdf. Accessed March 22, 2019.

0. 838.  General Mills. Re: Interagency Working Group on Food Marketed to Children: FTC Project No. P094513 Comments on Proposed Nutrition Principles and General Comments and Proposed Marketing Definitions. Washington, D.C. Published July 14, 2011.

0. 839.  Jackson T. Dear Chairman Leibowitz. Ohio Grocers Association. 2011.

0. 840.  General Mills. Re: Interagency Working Group on Food Marketed to Children: FTC Project No. P094513 Comments on Proposed Nutrition Principles and General Comments and Proposed Marketing Definitions. Washington, D.C. Published July 14, 2011.

0. 841.  Vladeck D. What’s on the table. Federal Trade Commission. Published July 1, 2011. Available at: https://www.ftc.gov/news-events/blogs/business-blog/2011/07/whats-table. Accessed March 22, 2019.

0. 842.  Dietz WH. New strategies to improve food marketing to children. Health Aff (Millwood). 2013;32(9):1652–8.

0. 843.  Wilson D, Roberts J. Special report: how Washington went soft on childhood obesity. Reuters. Published April 27, 2012. Available at: https://www.reuters.com/article/us-usa-foodlobby/special-report-how-washington-went-soft-on-childhood-obesity-idUSBRE83Q0ED20120427. Accessed March 22, 2019.

0. 844.  Wilson D, Roberts J. Special report: how Washington went soft on childhood obesity. Reuters. Published April 27, 2012. Available at: https://www.reuters.com/article/us-usa-foodlobby/special-report-how-washington-went-soft-on-childhood-obesity-idUSBRE83Q0ED20120427. Accessed March 22, 2019.

0. 845.  Wilson D, Roberts J. Special report: how Washington went soft on childhood obesity. Reuters. Published April 27, 2012. Available at: https://www.reuters.com/article/us-usa-foodlobby/special-report-how-washington-went-soft-on-childhood-obesity-idUSBRE83Q0ED20120427. Accessed March 22, 2019.

0. 846.  Wilson D, Roberts J. Special report: how Washington went soft on childhood obesity. Reuters. Published April 27, 2012. Available at: https://www.reuters.com/article/us-usa-foodlobby/special-report-how-washington-went-soft-on-childhood-obesity-idUSBRE83Q0ED20120427. Accessed March 22, 2019.

0. 847.  Gerberding JL. Safer fats for healthier hearts: the case for eliminating dietary artificial trans fat intake. Ann Intern Med. 2009;151(2):137–8.

0. 848.  Galizzi MM. Label, nudge or tax? A review of health policies for risky behaviours. J Public Health Res. 2012;1(1):14–21.

0. 849.  Mozaffarian D, Rogoff KS, Ludwig DS. The real cost of food: can taxes and subsidies improve public health? JAMA. 2014;312(9):889–90.

0. 850.  Barragan NC, Noller AJ, Robles B, et al. The “sugar pack” health marketing campaign in Los Angeles County, 2011–2012. Health Promot Pract. 2014;15(2):208–16.

0. 851.  Processed meat is the next public health crisis. Physicians Committee for Responsible Medicine. Published March 20, 2012. Available at: https://www.pcrm.org/news/blog/processed-meat-next-public-health-crisis. Accessed November 26, 2018.

0. 852.  Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993;341(8845):581–5.

0. 853.  Astrup A. The trans fatty acid story in Denmark. Atheroscler Suppl. 2006;7(2):43–6.

0. 854.  McCarthy M. US moves to ban trans fats. BMJ. 2013;347:f6749.

0. 855.  Gerberding JL. Safer fats for healthier hearts: the case for eliminating dietary artificial trans fat intake. Ann Intern Med. 2009;151(2):137–8.

0. 856.  Cohen JT. FDA’s proposed ban on trans fats: how do the costs and benefits stack up? Clin Ther. 2014;36(3):322–7.

0. 857.  Angell SY, Silver LD, Goldstein GP, et al. Cholesterol control beyond the clinic: New York City’s trans fat restriction. Ann Intern Med. 2009;151(2):129–34.

0. 858.  European Dairy Association. Trans fatty acids: questions & answers. EDA.Euromilk.org. Published 2015. Available at: http://eda.euromilk.org/fileadmin/user_upload/Public_Documents/Nutrition_Factsheets/EDA-Nutrition_fact_sheet_Q_A_On_Trans_Fatty_Acids.pdf. Accessed March 22, 2019.

0. 859.  Reeves RM. Effect of dietary trans fatty acids on cholesterol levels. N Engl J Med. 1991;324(5):338–40.

0. 860.  Brownell KD, Pomeranz JL. The trans-fat ban—food regulation and long-term health. N Engl J Med. 2014;370(19):1773–5.

0. 861.  Resnik D. Trans fat bans and human freedom. Am J Bioeth. 2010;10(3):27–32.

0. 862.  Ferrara P. Rise of food fascism. Washington Times. Published May 31, 2003. Available at: https://www.washingtontimes.com/news/2003/may/31/20030531-092643-1371r. Accessed March 22, 2019.

0. 863.  Ross GL. Determining the benefits of the New York City trans fat ban. Ann Intern Med. 2010;152(3):194.

0. 864.  Gostin LO. Bloomberg’s health legacy: urban innovator or meddling nanny? Hastings Cent Rep. 2013;43(5):19–25.

0. 865.  National Federation of Independent Business, et al. v. Sebelius, Secretary of Health and Human Services, et al. 567 U.S. 519 11-393 (Roberts Court 2011).

0. 866.  Bork R. The Tempting of America. New York: Free Press; 1997.

0. 867.  Angell SY, Silver LD, Goldstein GP, et al. Cholesterol control beyond the clinic: New York City’s trans fat restriction. Ann Intern Med. 2009;151(2):129–34.

0. 868.  Restrepo BJ, Rieger M. Trans fat and cardiovascular disease mortality: evidence from bans in restaurants in New York. J Health Econ. 2016;45:176–96.

0. 869.  Coombes R. Trans fats: chasing a global ban. BMJ. 2011;343:d5567.

0. 870.  Kirkwood K. Lipids, liberty, and the integrity of free actions. Am J Bioeth. 2010;10(3):45–6.

0. 871.  Golan E, Kuchler F, Krissow B. Do food labels make a difference? Sometimes. United States Department of Agriculture. Published November 1, 2007. Available at: https://www.ers.usda.gov/amber-waves/2007/november/do-food-labels-make-a-difference-sometimes. Accessed March 22, 2019.

0. 872.  Hoyte v. Yum! Brands, Inc. 567 U.S. 519 06-1127 (United States District Court, District of Columbia, 2006).

0. 873.  Brownell KD, Warner KE. The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? Milbank Q. 2009;87(1):259–94.

0. 874.  Jargon J. The gluten-free craze: is it healthy? Wall Street Journal. Published June 22, 2014. Available at: https://www.wsj.com/articles/how-we-eat-the-gluten-free-craze-is-it-healthy-1403491041. Accessed March 22, 2019.

0. 875.  “Gluten free” claims in the marketplace. Agriculture and Agri-Food Canada. Published April 2014. Available at: http://www.agr.gc.ca/eng/industry-markets-and-trade/canadian-agri-food-sector-intelligence/processed-food-and-beverages/trends-and-market-opportunities-for-the-food-processing-sector/gluten-free-claims-in-the-marketplace. Accessed March 22, 2019.

0. 876.  Jargon J. The gluten-free craze: is it healthy? Wall Street Journal. Published June 22, 2014. Available at: https://www.wsj.com/articles/how-we-eat-the-gluten-free-craze-is-it-healthy-1403491041. Accessed March 22, 2019.

0. 877.  Fry L, Madden AM, Fallaize R. An investigation into the nutritional composition and cost of gluten-free versus regular food products in the UK. J Hum Nutr Diet. 2018;31(1):108–20.

0. 878.  Elliott C. The nutritional quality of gluten-free products for children. Pediatrics. 2018;142(2):e20180525.

0. 879.  He FJ, Pombo-Rodrigues S, MacGregor GA. Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open. 2014;4(4):e004549.

0. 880.  Dunford E, Webster J, Woodward M, et al. The variability of reported salt levels in fast foods across six countries: opportunities for salt reduction. CMAJ. 2012;184(9):1023–8.

0. 881.  Coyne KJ, Baldridge AS, Huffman MD, Jenner K, Xavier D, Dunford EK. Differences in the sodium content of bread products in the USA and UK: implications for policy. Public Health Nutr. 2018;21(3):632–6.

0. 882.  Wyness LA, Butriss JL, Stanner SA. Reducing the population’s sodium intake: the UK Food Standards Agency’s salt reduction programme. Public Health Nutr. 2012;15(2):254–61.

0. 883.  Roehr B. US tops salty fast food league table. BMJ. 2012;344:e2769.

0. 884.  Ma Y, He FJ, Yin Y, Hashem KM, MacGregor GA. Gradual reduction of sugar in soft drinks without substitution as a strategy to reduce overweight, obesity, and type 2 diabetes: a modelling study. Lancet Diabetes Endocrinol. 2016;4(2):105–14.

0. 885.  Hill JO. Can a small-changes approach help address the obesity epidemic? A report of the Joint Task Force of the American Society for Nutrition, Institute of Food Technologists, and International Food Information Council. Am J Clin Nutr. 2009;89(2):477–84.

0. 886.  Brownell KD. Government intervention and the nation’s diet: the slippery slope of inaction. Am J Bioeth. 2010;10(3):1–2.